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ABSTRACT	  
Recent studies on the genetics of complex human disease have been successful in 
identifying associated variants, but very few statistically significant associations have 
been resolved to the level of a specific gene, mutation or molecular mechanism. Also 
left unresolved are questions about the nature of this variation — the total number of 
loci involved, the magnitude of their effects, and their frequency distribution. Here, we 
describe a complementary approach using Drosophila melanogaster to create a genetic 
model of a human disease — permanent neonatal diabetes mellitus — and present 
experimental results describing dimensions of this complexity. The approach involves 
the transgenic expression of a misfolded mutant of human preproinsulin, hINSC96Y, 
which is a cause of permanent neonatal diabetes. When expressed in fly imaginal discs, 
hINSC96Y causes a reduction of adult structures, including the eye, wing and notum. Eye 
imaginal discs exhibit defects in both the structure and arrangement of ommatidia. In 
the wing, expression of hINSC96Y leads to ectopic expression of veins and mechano-
sensory organs, indicating disruption of wild type signaling processes regulating cell 
fates. These readily measurable “disease” phenotypes are sensitive to temperature, 
gene dose and sex. Mutant (but not wild type) proinsulin expression in the eye imaginal 
disc induces IRE1-mediated Xbp1 alternative splicing, a signal for endoplasmic 
reticulum (ER) stress response activation, and produces global change in gene 
expression. Mutant hINS transgene tester strains, when crossed to stocks from the 
Drosophila Genetic Reference Panel (DGRP) produces F1 adults with a continuous 
range of disease phenotypes and large broad-sense heritability. Surprisingly, the 
severity of mutant hINS-induced disease in the eye is not correlated with that in the 
notum in these crosses, nor with eye reduction phenotypes caused by the expression of 
two dominant eye mutants acting in two different eye development pathways, Drop (Dr) 
or Lobe (L) when crossed into the same genetic backgrounds. The tissue specificity of 
genetic variability for mutant hINS-induced disease has, therefore, its own distinct 
signature. The genetic dominance of disease-specific phenotypic variability in our model 
of misfolded human proinsulin makes this approach amenable to genome-wide 
association study (GWAS) in a simple F1 screen of natural variation.	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INTRODUCTION	  
Model organisms are widely employed in mechanistic studies of human Mendelian 
disease (BEDELL et al. 1997a; BEDELL et al. 1997b; CHINTAPALLI et al. 2007; LIESCHKE 
and CURRIE 2007; OCORR et al. 2007; PASSADOR-GURGEL et al. 2007; SCHLEGEL and 
STAINIER 2007; LESSING and BONINI 2009). They are likewise an important resource for 
investigating the genetic underpinnings of continuously varying quantitative traits 
(PALSSON and GIBSON 2004; TELONIS-SCOTT et al. 2005; WANG et al. 2005; DWORKIN and 
GIBSON 2006; WANG et al. 2006; BERGLAND et al. 2008; GIBSON and REED 2008; 
AYROLES et al. 2009; DWORKIN et al. 2009; GOERING et al. 2009; MACKAY et al. 2009; 
MACKAY 2010; MACKAY 2011).  Numerous models of human disease have been 
established in the fly (reviewed in (PANDEY and NICHOLS 2011)), including transgenic 
models of diseases ranging from neurodegeneration / retinal degeneration (BILEN and 
BONINI 2005; RYOO et al. 2007; LESSING and BONINI 2009; YU and BONINI) to cancer 
(RUDRAPATNA et al. 2012). Success with genetic screens to identify suppressors and 
enhancers of disease when mutants are over-expressed in a developing tissue, such as 
the eye-antennal imaginal disc, suggested to us that it might be possible to generate a 
fly model of misfolded-insulin-associated diabetes.  
A number of dominant mutations in human proinsulin have been identified in 
patients with permanent neonatal diabetes (STOY et al. 2007; STOY et al. 2010). One 
class of these involves mutations leading to an unpaired cysteine. The mutation of Cys-
96 to Tyr — hINSC96Y — abolishes a disulfide bridge between the A- and B-chains of the 
polypeptide, causing proinsulin to misfold and accumulate in the endoplasmic reticulum 
(ER). Induction of the unfolded protein response (UPR), caused by ER stress, ultimately 
leads to pancreatic beta-cell death (OYADOMARI et al. 2002; HARTLEY et al. 2010).  
Mutant-insulin-induced diabetes may also be a model for the more common type 2  
(adult onset) form of diabetes, where increased demand for insulin overwhelms the 
pathways regulating protein folding and trafficking. In this case, the accumulation of 
misfolded wild type proinsulin in the ER is hypothesized to trigger pathways that 
respond to loss of proteostatic control (OYADOMARI et al. 2002; SCHEUNER and KAUFMAN 
2008).  
Many signaling mechanisms regulating proteostasis — the dynamics of protein 
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expression and turnover including folding, processing, transport, regulation and 
degradation — are conserved between fly and human (GEMINARD et al. 2009; KARPAC 
and JASPER 2009; HASELTON and FRIDELL 2010; BITEAU et al. 2011). Misfolded alleles of 
rhodopsin, for example, cause age-related retinal degeneration in both species. In the 
fly model, overexpression of ninaE (a mutant allele of the fly ortholog of human 
rhodopsin-1) in the eye-antennal imaginal disc induces ER-stress-associated UPR and 
pro-apoptotic signaling, resulting in adult-onset eye degeneration (RYOO et al. 2007; 
KANG and RYOO 2009; MENDES et al. 2009; KANG et al. 2012). Strongly conserved 
signaling mechanisms in these pathways led us to reason that over-expression of 
mutant human preproinsulin (hINSC96Y) in the fly would likewise unleash UPR and cell 
death, thus recapitulating biological processes acting in the human form of the disease. 
To test this prediction we created a transgenic model of permanent neonatal 
diabetes in the fly by expressing hINSC96Y under regulatory control of the UAS-Gal4 
system. We drove hINS expression in larval/pupal imaginal discs, precursors of adult 
structures, and measured the loss of adult tissue, expected if the mutant activated cell 
death pathways. We also examined phenotypes in flies expressing wild type human 
preproinsulin (hINSWT) as a control. Here we describe phenotypic characteristics of this 
Mendelian model of disease, including sex-specific differences, dosage, environmental 
sensitivity, and reorganization of gene expression.  
Type 2 or adult-onset diabetes is a complex disease whose genetic underpinnings 
have proved challenging to identify in human studies (TANEERA et al. 2012). A rationale 
for introducing a mutant gene into the fly to create a Mendelian model of disease, as for 
example with unstable polyglutamine triplet repeat proteins (BILEN and BONINI 2007; 
LESSING and BONINI 2008; YU and BONINI), is to create a genotype that is “sensitized” to 
the presence of disease modifiers. What if, rather than screening for these modifiers in 
forward genetic screens with laboratory-produced mutants, the same genetically 
sensitized flies are used to screen wild genetic backgrounds for naturally occurring 
modifiers of disease? With Drosophila having 20-40 times greater density of single 
nucleotide polymorphisms (SNPs) than human, and being genetically variable for most 
phenotypic traits, we expected this genetic screen to expose abundant genetic variation 
for the severity of disease phenotypes.  
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We examined dominant and partially-dominant genetic variation for disease severity 
by crossing a panel of inbred lines derived from a natural population sample (DGRP, 
(MACKAY et al. 2012)) to a tester stock carrying both the mutant insulin transgene and 
an eye imaginal disc-specific Gal4 expression driver on the same chromosome 
(GMR>>hINSC96Y). Measuring the effects of natural modifiers in outcrossed flies avoids 
inbreeding effects in the isogenic lines and better mimics their heterozygosity in natural 
populations, especially low-frequency variants. Repeated measurements of genetically 
identical F1 flies also reduces non-genetic variance components compared to individual 
measurements, increasing the power to detect genetic differences (MACKAY et al. 2009). 
By examining adult eye reduction in F1 flies, we quantify disease phenotypes in different 
genetic backgrounds, and describe its distribution of effects in a natural population 
sample. 
We then investigated biological properties of the naturally occurring genetic 
variation unleashed by our model of proteostatic disease. We first determine the 
correlation structure of hINSC96Y-induced phenotypes in the adult eye and notum when 
hINSC96Y is expressed in their respective imaginal discs in a set of DGRP lines. We 
provide evidence for different alleles or loci modifying the disease in the two tissues, 
contrary to our expectation that the same alleles would be acting. This result led us to 
investigate genetic variation acting in eye-specific developmental pathways. We 
measured eye reduction in the same DGRP lines in crosses to two classical dominant 
eye mutants, Drop (Dr) and Lobe (L), and found that both are also uncorrelated with eye 
reduction induced by hINSC96Y expression. The presence of tissue- and disease-specific 
modifiers in our model of a human Mendelian disease, affirms the suitability of 
Drosophila as a model for investigating genetically complex forms of human disease. 
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MATERIALS AND METHODS 
Drosophila stocks	  
The Drosophila stocks used in this study are described in Table 1.	  
Table 1  Drosophila stocks 
Stock Genotype Reference Comment 
hINS transgene   
 WT-24; WT-6 P(UAS-hINSWT) 
w1118 background 
This study Wild type human proinsulin; 2nd 
chromosome insertion site 
M-1; M-101 P(UAS-hINSC96Y) 
w1118 background 
This study Mutant human proinsulin; 2nd 
chromosome insertion site 
Gal4 drivers 
GMR-Gal4 w*; P{Gal4-
ninaE.GMR}12 
#1104 
(Bloomington)  
Expresses in eye disc morphogenetic 
furrow 
ap-Gal4 ap-Gal4/CyO #25686 
(Bloomington) 
Expresses in developing mesothorax 
(notum) 
en-Gal4 en-Gal4 ciBe/CyO  
Act5c-GFP 
From R. Fehon Expressing in ventral compartment of 
wing imaginal disc 
dpp-Gal4 dppblnk-Gal4, UAS-
GFPNLS/TM6B 
From R. Fehon Expresses between dorsal and ventral 
compartments of wing imaginal disc 
[Gal4 driver], [hINS]; Gal-4 driver, hINS same chromosome 
GMR>>hINSWT 
GMR>>hINSC96Y 
w1118; GMR-Gal4, 
UAS-hINSWT or C96Y,  
UAS-GFP / CyO 
This study GMR-Gal4 driver recombined onto 
hINS-bearing chromosome (WT-24 or 
M-1) 
ap>>hINSWT 
ap>>hINSC96Y 
w1118; ap-Gal4, UAS-
hINSWT or C96Y/ CyO 
This study ap-Gal4 driver recombined onto hINS-
bearing chromosome (WT-24 or M-1) 
Other stocks 
Drop (Dr) w1118; Dr1 /TM3,  
twist-GFP 
From R. Fehon Reduced eye size; acts through Jak/Stat 
pathway in ventral eye development 
Lobe (L) L(1) #318 
(Bloomington) 
Muscle segment homeobox-1 
transcription factor; induces apoptosis in 
developing eye 
Scutoid (Sco) w1118; CyO dfd- 
YFP /snaSco 
From R. Fehon Missing bristles on notum 
DGRP Inbred wild lines Bloomington  “Core 38 ” used in these experiments 	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Crosses	  
Flies were maintained on standard commercial medium at 25°C. Mutant and wild type 
hINS phenotypes, including adult and imaginal disc morphology and gene expression, 
were examined in F1 flies produced by crosses between stocks carrying a hINS 
transgene (M-1 or WT-24) and a tissue-specific Gal4 driver (GMR-Gal4, ap-Gal4, en-
Gal4 or dpp-Gal4). To examine hINS phenotypes in outcrossed genetic backgrounds, 
we crossed DGRP inbred stocks with a “tester” stock in which a Gal4 driver (GMR-Gal4 
or ap-Gal4) was recombined onto a second chromosome carrying a hINS transgene 
(designated GMR>>hINS or ap>>hINS; Table 1). For each cross, and also crosses 
between DGRP stocks and L or Dr, 5 healthy virgin females from the tester stock were 
mated with 5-10 healthy males from each the DGRP stocks. Parents were transferred to 
fresh culture bottles every two days for 8 days. Phenotypes were measured separately 
in a minimum of 10 individuals for each sex. Eye measurements were made on 3-5 day 
old adults only. This particular trait, however, is stable in adults and has good 
replicability (Figure S1). The crosses between the tester stock and DGRP stocks were 
generally carried out in a single block to minimize experimental error. 	  	  
Transgene construction and P-element-mediated transformation 	  
Gal4/UAS system was used for ectopic gene expression of the wild type and mutant 
(C96Y) human preproinsulin (ST JOHNSTON 2002). Transgenic human preproinsulin wild 
type (hINSWT) and mutant (hINSC96Y) flies were generated by subcloning the human 
preproinsulin cDNA (BELL et al. 1979) into the Drosophila transformation vector pUAST 
(https://dgrc.cgb.indiana.edu/vectors/). Transformation was carried out as described in 
(SPRADLING et al. 1995). Mapping crosses are described in (LUDWIG et al. 1993). For the 
UAS-hINSWT and UAS-hINSC96Y constructs, we generated 8 and 19 independently 
transformed stocks, respectively, each of which contained a single transposon insertion. 
For each of two constructs (WT and C96Y) at least one insertion in each of the three 
major chromosomes of D. melanogaster was generated to control for the influence of 
position effect on transgene expression.  	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Immunohistochemistry 	  
Drosophila third instar wandering larvae of either sex were dissected in phosphate 
buffered saline (PBS).  Isolated discs (approximately 5 pairs per sample) were placed in 
a glass tube with 4% paraformaldehyde in PBS and incubated for 30-40 min at room 
temp. Discs were then washed 3 times in PBS, 5 min each, and treated with 1% Triton 
X-100 in PBS for 30 min at room temperature. Discs were washed again 3 times by 
PBS/5 min each and treated with 5% Normal Donkey Serum (NDS) in PBS.  Staining 
with a mixture of mouse anti-human C-peptide (Millipore; 1:200) and rat anti-ELAV 
(Developmental Studies Hybridoma Bank, University of Iowa, IA; 1:200) was performed 
in PBS with 1% NDS.  Secondary antibodies were from Jackson ImmunoResearch.   
After staining, imaginal discs were removed with a glass pipette coated with NDS, 
placed in a drop of “SlowFade Gold with DAPI” antifade solution (Invitrogen) and 
covered with a glass coverslip. Staining was observed with a Leica SP2 laser scanning 
confocal microscope with 20x or 63x objectives.	  	  
Transcriptional profiling 	  
Total RNA from 12 eye imaginal discs from each stock was isolated from wandering 
third instar larvae using MELTTM Total Nucleic Acid Isolation System (Ambion). The 
quality and quantity of each RNA sample was checked using a 2100 BioAnalyzer 
(Agilent) and Nanodrop 1000 (Thermo Scientific). Amplification of total RNA and 
synthesis of cDNA was carried out using the OvationTM RNA Amplification System V2 
(NuGen Technologies) from 100 ng of total RNA. The amplified cDNA was purified 
using Zymo-Spin II Column (Zymo Research Clean and ConcentratorTM-25, Zymo 
Research). 3.75 µg of fragmented and labeled single-stranded cDNA targets were 
generated by the FL-OvationTM cDNA Biotin Module V2 (NuGen) and hybridized to each 
Affymetrix-GeneChip® Drosophila Genome 2.0 Array. Four microarrays were used to 
estimate transcript levels for each of five genotypes (2 males and 2 females each): 
control (GMR-Gal4) expressing the Gal4 activator protein only; hINSWT line 6 (hereafter 
WT-6); hINSWT line 24 (WT-24); hINSC96Y line 101 (M-101); and hINSC96Y line 1 (M-1). 
The two lines of each genotype, hINSWT or hINSC96Y, were selected to represent 
moderate and high expression of the hINS transgene. Microarray data are available at 
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the Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo) with 
accession number GSE43128.	  
 
Analysis of microarray data 
Intensity data for each feature on the array was calculated from the images generated 
by the GenChip® Scanner 3000 7G (Affymetrix) and the data files were extracted using 
GeneChip Operating Software (MicroArray Suite 5.0 software, Affymetrix). We 
performed background subtraction and normalization of CEL files both in dChip (2010.1) 
software with its default parameter (5th percentile of PM-probes as baseline for 
background subtraction, invariant set for normalization). 	  
 Data analysis 1: We used Partek software (Partek Inc., v6.5) initially to identify 
differentially expressed genes in the comparison between GMR-Gal4 background and 
each transgenic fly (GMR-Gal4/UAS-hINSWT or INSC96Y, 4 genotypes).  Sexes were 
analyzed separately. A one-way ANOVA was performed with genotype as a fixed effect. 
All genes for which the effect of genotype was significant at a false discovery rate (FDR) 
of 10% were further tested to determine whether mean expression of GMR-Gal4/UAS-
hINSWT or GMR-Gal4/UAS-hINSC96Y was significantly different from the control (GMR-
Gal4). 	  
 Data analysis 2: The normalized intensity data were log2 transformed for 
subsequent analyses implemented using R-bioconductor (v 2.10.0). To compare the 
transcriptional responses to the expression of wild type or mutant hINS, we restricted 
the analysis to a single pair of the transgenic lines, WT-24 and M-1, matched for high 
level of hINS expression based on quantitative real-time PCR (qRT-PCR), together with 
the control (GMR-Gal4), and performed independent ANOVA for each array feature 
under the model Yijk = u + Li + Sj + eijk, where Li = line (i = 1, 2 or 3), Sj = sex (j = 1 or 2) 
and eijk = error (k = 1 or 2). We applied Benjamini–Hochberg–Yekutieli procedure 
(BENJAMINI and YEKUTIELI 2001) on the resulting p-values to control FDR.	  	  
Quantitative RT-PCR 	  
Total RNA was isolated from heads of 30 adult flies using Trizol reagent (Invitrogen) 
and from eye-antennal imaginal discs from 12 wandering late-third instar larvae using 
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MELTTM Total Nucleic Acid Isolation System (Ambion). cDNA synthesis was performed 
using oligo dT-primer and Superscript® III First-Strand Synthesis System (Invitrogen). 
Quantitative RT-PCR was carried out using a StepOne™Real-Time PCR System (ABI) 
in triplicate. Gene-specific sets of primers (Table S1) and SYBR green PCR master mix 
(ABI) were used to quantify gene expression. The results was normalized to the 
expression of rp49 expression.	  	  
Analysis of Xbp1 mRNA splicing 	  
Total RNA was isolated from wandering late-third instar larvae and cDNA synthesized, 
as described above. To visualize the alternative splicing of the 23 bp Xbp1 intron, a 
diagnostic marker of UPR induction (COX and WALTER 1996; MORI et al. 2000; SHEN et 
al. 2001; YOSHIDA et al. 2001), PCR was carried out using the D. melanogaster-specific 
primers 5’- AACAGCAGCACAACACCAGA-3’ (forward) and 5’-
CGCCAAGCATGTCTTGTAGA-3’ (reverse), which amplifies fragments of 239 bp for 
unspliced Xbp1 (Xbp1-U) and 216 bp for spliced Xbp1 (Xbp1-S). The PCR conditions 
were initial denaturation at 94°C for 3 min, and 35 cycles of denaturation at 94°C for 30 
sec, annealing at 57°C for 30 sec and extension at 72°C for 1 min, and a final extension 
at 72°C for 10 min.  PCR products were separated by 10% PAGE and visualized by 
ethidium bromide staining. PCR products were also digested with PstI to better 
distinguish the spliced and unspliced forms of Xbp1 mRNA variants. 	  	  
Eye measurement	  
Low magnification images were captured with a Zeiss AxioCam HRc mounted on a 
Leica MZ16 fluorescent stereomicroscope. For high magnification images eyes were 
mounted in Halocarbon 700 oil (Sigma) and were captured with a Zeiss AxioCam HRc 
camera on the Zeiss Axioscope microscope.	  
Three to five day old adults of the appropriate genotype from each cross (in some 
experiments following thorax measurement) were placed on a slide containing a thin 
layer of silicone vacuum grease (Beckman), and mounted in Halocarbon 700 oil under a 
cover slip supported by capillary tubes. Eyes were photographed using a Leica DFC420 
camera mounted on a Leica M205 FA stereomicroscope.  The Leica Application Suite 
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software and ImageJ software (rsb.info.hih.gov/ij/) were used to analyze merged Z-
stacks taken on the Leica M205 FA microscope. Only eyes with borders and head 
capsules in the same optical section were analyzed. At least 10 females and (or) males 
from a given cross were measured to obtain the average for each genotype. Eye area 
measurements are robust over across independent experiments (Figure S1).	  	  
Thorax measurement	  
Thorax lengths (the distance from the base of the most anterior humeral bristle to the 
posterior tip of the scutellum) were measured using a Nikon SMZ-2B microscope 
equipped with a mechanical stage and built-in micrometer.	  	  
Wing measurement 	  
For each cross 5 healthy virgin females from both the dpp-Gal4 and en-Gal4 stocks 
were mated with 5-10 healthy males from w1118 (control), WT-24 and M-1 stocks.  
Flies of the appropriate genotype were incubated in 70% ethanol for at least 24 hr.  
Wings were mounted in Aqua PolyMount (Polysciences, Inc.) on a glass slide. Only 
wings that had been flattened during the mounting process were used for further 
analysis.  Images were captured using a Zeiss Axioscop microscope equipped with an 
AxioCam HRc camera and imported into Image J for analysis. Wing sizes in case of the 
en-Gal4 driver were quantified by measuring the posterior area divided by total wing 
area. Wing sizes in case of the dpp-Gal4 driver were quantified by measuring the area 
of sectors L4 and L3 area divided by sectors L2-L4 area. Significance was determined 
by the Mann-Whitney U test.	  	  
Bristle count	  
Three to five days old flies of the appropriate genotype (25 males and 25 females) were 
placed in Halocarbon 700 oil. The presence or absence of 26 bristles (macrochaetae; 
Figure S2) on the notum, including humeri, was scored.  	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RESULTS	  
Transgene analysis	  
We generated transgenic flies carrying a single copy of either wild type or mutant 
human preproinsulin (hINSWT and hINSC96Y, respectively), whose expression is 
regulated by a UAS:Gal4 promoter. A total of 27 independent transgenic stocks were 
produced, eight carrying hINSWT and 19 carrying hINSC96Y, allowing us to investigate 
and control for position effects on gene expression. The hINSWT lines also gave us the 
ability to identify mutation-dependent phenotypes in hINSC96Y distinct from those 
resulting from both protein over-expression and/or interactions with native Drosophila 
Insulin Like Peptides (DILPs) dependent pathways. 	  
We investigated disease phenotypes by expressing transgenic hINS in imaginal 
discs of the eye (GMR-Gal4 driver), wing (en-Gal4 and dpp-Gal4 drivers), and notum 
(ap-Gal4 driver). The eye system was studied in greater detail than the others. GMR-
Gal4 directs hINS transgene expression to developing photoreceptor neurons and 
surrounding support eye cells in the eye-morphogenetic furrow 
(http://flystocks.bio.indiana.edu/Reports/9146.html) (FREEMAN 1996). We confirmed 
transgene expression in F1 adult heads by qRT-PCR (data not shown) and the 
presence of hINS protein in late 3rd instar larval imaginal discs of GMR-Gal4 / UAS-
hINSC96Y (or UAS-hINSWT) individuals by immunoflourescent staining with an antibody 
specific for hINS C-peptide (Figure 1 I-L). 	  
We then examined the adult eye phenotypes caused by the mutant transgene 
expression in comparison to GMR-Gal4 controls. All adult GMR-Gal4 and GMR-
Gal4/UAS-hINSWT (eight lines) flies exhibited completely wild type eyes. In contrast, five 
of the mutant GMR-Gal4/UAS-hINSC96Y lines showed a severe eye phenotype: a 
reduction in eye size, reduced number of eye bristles, the presence of lesions with no 
evidence of cells, and collapse of ommatidia structure and normal array pattern. Six 
lines showed a moderate eye phenotype with a small reduction in eye size and eight 
lines had no obvious phenotype.  
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Figure 1 Eye phenotypes induced by hINSC96Y transgene expression.  (A-D) Eyes of 3-
5 day-old adults. (A) Female, GMR-Gal4. (B) Female, GMR-Gal4 / UAS-hINSWT. (C) 
Female, GMR-Gal4 / UAS-hINSC96Y. (D) Male, GMR-Gal4 / UAS-hINSC96Y. (E-H) High 
magnification images of adult eyes above showing defects in patterning of ommatidia 
and mechanosensory bristles. (I-H) Eye-antennal imaginal discs of third-instar larvae of 
genotypes noted in (A-D) stained with anti-human C-peptide antibody (red). (M-P) Discs 
in (panels I-H above) stained with anti-ELAV antibody (green); insets (panels M-P) show 
enlarged area of most posterior part of eye disc. 	  
 
We first tested and could reject the formal possibility that the mutant insulin 
transgenes are expressed at higher levels than the wild type hINS transgenes, as could 
be caused by insertion-site position effects. hINS transcript levels were quantified by 
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qRT-PCR from total RNA of late 3rd instar larval eye-imaginal discs from two mutant 
hINS lines, one exhibiting a mild eye phenotype (M-101) and the other a more severe 
eye phenotype (M-1), and found significantly greater expression in the line with the 
more severe eye phenotype (Figure 2A). This comparison establishes the C96Y 
mutation as being both necessary and sufficient to cause an eye degeneration 
phenotype. Subsequent analyses were carried out with a high-expressing mutant hINS 
line (M-1) and a matched wild type-hINS-expressing control (WT-24).	  
Figure 2 Gene expression in eye-antennal imaginal discs of third-instar larva. (A) 
Relative mRNA levels in discs from larva expressing wild type (WT) and mutant (M, 
hINSC96Y) human proinsulin. WT-6, WT-24, M-101 and M-1 are independent transgenic 
lines. Gene expression is normalized to the expression level of rp49. The values (mean 
± SE) are shown relative to the ratio for female WT-6, set to one. (B) Heat map of 
expression profiles in rows (genes) and columns (lines x sex) for top 514 genes based 
on ANOVA between WT-24 and M-1 and the GMR-Gal4 control line are compared. 
ANOVA was performed for the three genotypes, two sexes, and two replicates 
according to the model y = u +G + S + G x S, where G is the genotype and S is gender. 
Each gene was tested individually. The resulting P-values were ordered and false 
discovery rate (FDR, q) was estimated using Hochberg and Benjamini’s method 
(HOCHBERG and BENJAMINI 1990). A list of 514 genes was selected to control FDR < 5%. 
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Each row is scaled to have mean 0 and variance 1. (C) Venn diagram showing the 
number of differentially expressed genes (up and down) in males and females in the 
comparison of WT-24 and M-1.	  
 
Eye phenotype	  
The adult eye in GMR-Gal4 / UAS-hINSC96Y flies displays a number of characteristic 
defects, most notably a reduction in size, which varied among the transgenic stocks. 
Individual ommatidia are often collapsed, lacking the wild type organization of 
photoreceptor cells, giving the eye a glassy punctate phenotype (Figure 1 C, D). The 
regular array structure of ommatidia across the eye field is also disrupted, with the 
individual hairs projecting from each one either disarrayed or absent (Figure 1 G, H). 
Finally, black lesions can be present within the eye field where no cellular structure is 
evident (Figure 1 D, H). Mutant phenotypes require only a single copy of hINSC96Y 
expression (i.e., GMR-Gal4 / UAS-hINSC96Y or UAS-hINSC96Y, GMR-Gal4 / CyO) but are 
more severe in double dose (i.e., UAS-hINSC96Y, GMR-Gal4 / UAS-hINSC96Y, GMR-
Gal4). 	  
The GMR-Gal4 driver activates expression in the cells posterior to the 
morphogenetic furrow in the eye discs (FREEMAN 1996). We therefore examined the 
organization and cellular structure of developing ommatidia by co-staining eye imaginal 
discs from late 3rd instar larvae with hINS anti-C peptide (a marker of proinsulin 
expression) (PARK et al. 2010) and an antibody against ELAV, a neuron-specific RNA-
binding protein widely used to stain rhabdomeres (ROBINOW and WHITE 1991). This 
allowed us to confirm expression of wild type and mutant proinsulin in the developing 
eye field (Figure 1 K, L). Ommatidial arrays at this early stage of eye formation are 
irregular and disorganized (Figure 1 O, P), indicating that the adult reduced-eye 
phenotype originates in the eye morphogenetic furrow with improper formation and 
maturation of photoreceptor cells, ommatidia, and ultimately the entire eye field.	  
The severity of the reduced-eye phenotype differs quantitatively between the two 
sexes. Mutant males in GMR-Gal4 / UAS-hINSC96Y flies exhibit a measurably stronger 
i.e., more degenerate, eye phenotype than females (Figure 1 C, G [female] vs. D, H 
[male]), a difference that is independent of gene dose, temperature, and genetic 
background (CARL 2010). This difference cannot be attributed to sex-specific difference 
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in hINS expression, which does not differ significantly in the eye imaginal discs of either 
in wild type or mutant hINS lines (Figure 2A). The male biased phenotype, moreover, is 
not restricted to eye development; it is also observed in the notum and the wing when 
hINSC96Y is expressed in the developing wing imaginal disc under the control of three 
other Gal4 drivers, as described below. The sex-biased phenotype appears to arise, 
therefore, not through tissue-specific development, but rather through a gender 
difference in cellular response to the mutant insulin protein.	  
 
Transcriptional profiles in eye imaginal discs expressing wild type and mutant 
hINS	  
To reveal the effect of expressing hINSC96Y at the transcription level, and to identify the 
key changes in expression underlying the disease phenotype, we compared expression 
profiles of 3rd instar imaginal discs isolated from the GMR-Gal4 driver line and lines 
expressing wild type and mutant proinsulin, using the Affymetrix-GeneChip® Drosophila 
Genome 2.0 Array. The experiments included two independent transgenic lines each for 
hINSWT and hINSC96Y, including the matched pair WT-24 and M-1 shown to express 
hINS mRNA at similarly high levels (Figure 2A). Compared to GMR-Gal4 control and 
accounting for sex differences, we found no evidence for any effect on gene expression 
by wild type hINS: no significant gene differences between the GMR-Gal4 control line 
and WT-6, and only a single difference in WT-24 at an FDR < 0.10 level (Figure S3). In 
contrast, 124 and 232 genes differed in males and females (respectively) between the 
mutant hINS lines and the GMR-Gal4 control. The effect on global gene expression 
caused by transgene expression can therefore be entirely attributed to the mutant 
proinsulin expression. 	  
We then analyzed differences in gene expression between WT-24 and M-1, 
finding 297 genes whose expression differed in males (189 up-regulated and 108 down-
regulated and 109 genes that differed in females (81 up-regulated and 28 down-
regulated) (Figure 2C; File S1). Of these, 91 overlapped between males and females 
(70 up-regulated and 21 down-regulated). In contrast, using the same criteria we found 
only four genes showing significant differences between the control and hINSWT – 
expressing lines in both sexes. Another way to look at this is by fitting an ANOVA model 
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to each gene for all three genotypes (M-1/WT-24/GMR-Gal4), accounting for sex effects 
(see Data analysis 2 in Materials and Methods), in which we identified 514 probe sets 
with significant genotype differences (File S2). A heat map (Figure 2B) illustrates the 
similarities between the transcription profiles of hINSWT and the control, and confirms at 
the molecular level the lack of a visible phenotype caused by hINSWT expression. It also 
highlights the reorganization of transcription induced by hINSC96Y expression.	  
Inspection of the genes whose expression changed in response to mutant hINS 
revealed genes involved in protein folding/modification, protein degradation, and 
defense response/programmed cell death (Table 2; Tables S2, S3), and include 
representatives in UPR and ER-associated degradation (ERAD) pathways. An unbiased 
and unsupervised clustering analysis using David tools for Gene Ontology (GO) terms 
showed the greatest enrichment in membrane-bound proteins, while heat-shock 
proteins were also enriched (Table S4). 
Although we did not observe a significant difference in the mRNA levels of the 
upstream regulators of the UPR (Ire1, PEK(PERK), Hsc70-3 (BiP; GRP78) and Xbp1) in 
the GeneChip analysis, a more sensitive analysis by qRT-PCR in male eye imaginal 
discs expressing mutant hINS compared to GMR-Gal4 control revealed significant 
increases in expression of PERK (CG2087), BiP (CG4147), XBP1 (CG9415), and a 
marginally significant increase of IRE1 (CG4583; P = 0.08) (Table S5). As a more 
definitive test for activation of UPR, we also examined XBP1 mRNA for UPR-associated 
splicing by IRE1, and found evidence for it in mutant hINS-expressing cells but not wild 
type or GMR-Gal4-expressing cells (Figure S4). To confirm the microarray data by an 
independent method, we validated expression levels in the five lines (GMR-Gal4, WT-6, 
WT-24, M-101, M-1) for five genes sets (CG3966, CG7130, CG10420, CG10160 and 
CG9150) whose expression were up-regulated in males (Figure 2C). The results 
showed excellent correspondence between microarray and qRT-PCR (Table S6).  
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Table 2 Selected genes up-regulated by GMR-Gal4 / USA-hINSC96Y in male eye imaginal discs 
Probe set Transcript Name Description (GO)1 Homolog2 
Protein modification/folding  
1639033_at3 CG9432-RB l(2)01289 Disulfide isomerase  
1623862_at3 CG3966-RA  ninaA  HSP4  
1628660_at3 CG7130-RA          CG7130  HSP4 binding DNAJB1 
1623247_at3 CG10420-RA                          CG10420  HSP4 SIL1 
1627525_a_at CG1333-RA  Ero1L Thiol-disulfide exchange ERO1LB 
1641511_at CG7394-RA TIM14 HSP4 binding DNAJC19 
1641563_at CG8286-RA                 P58IPK  HSP4 binding DNAJC3 
1634528_at CG8412-RA  CG8412 Glycosyltransferase ALG12 
1638456_at   CG8531-RA CG8531  HSP4 binding   
Protein degradation  
1632071_at CG8870-RA   CG8870  Serine-type endopeptidase 
activity 
 
1637515_s_at3 CG1512-RA  Cullin-2 Ubiquitin-protein ligase CUL2 
1626272_s_at3 CG3066-RA Sp 7 Peptidase SP7 
1626460_at CG2658-RA                                               CG2658  Peptidase SPG7 
1635051_a_at CG14536-RA                    Herp                             Ubiquitin-protein ligase HERPUD2 
1634486_at CG30047-RA CG30047  Peptidase  
1624372_at CG10908-RA Derlin-1 Peptidase DERL1 
1637955_a_at3 CG1827-RA  CG1827  Lysosome  
1625253_at CG4909-RA              POSH  Ubiquitin-protein ligase SH3RF1 
1623029_at CG31535-RA                             CG31535 Ubiquitin-protein ligase  
1634899_a_at CG6512-RA CG6512 Peptidase AFG3L2 
Defense response/programmed cell death  
1636668_at CG9972-RA  CG9972  Apoptosis5  
1624450_at CG6331-RA                           Orct Apoptotic process  
1633145_at CG4437-RA PGRP-LF  Apoptosis5 PGLYRP3 
1622979_a_at CG7188-RB  Bax inhibitor-1  Apoptosis5  
1641298_at CG10535-RA Elp1 Defense response  
1634714_at CG1676-RA                                 Cactin  Defense response C19orf29 
1635028_s_at CG33047-RA                  Fuca Defense response FUCA2 
1638100_s_at CG1228-RD Ptpmeg  Apoptotic process PTPN4 
1628174_at CG33119-RA                         nim B1 Defense response  
 
1 GO molecular function/process from http://www.flybase.org, www.uniprot.org and http://david.abcc.ncifcrf.gov 
2 Human homolog from  http://flight.icr.ac.uk 
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3 Up-regulated in female and male 
4 Heat shock protein 
5 Negative regulation 	  
Expression of wild type and mutant hINS in the notum and wing	  
Expression of mutant (but not wild type) hINS in the notum, driven with an apterous 
driver (ap-Gal4), causes a reduction in the posterior margin of the notum and a loss of 
macrochaetae (Figure 3 C, D). The adult fly notum has 22 macrochaetae on the notum 
(Figure S2), which in ap>>hINSC96Y flies is reduced by an average of 8.3 and 13.4 
bristles in females and males, respectively (Table S7). This 40% sex differential in  
 Figure 3 Notum and wing phenotypes induced by hINSC96Y transgene expression. 
Notum (A-D) and wing (E-J) phenotypes in 3-5-day old adults of indicated sex and 
genotype. Insets show a higher magnification view of the anterior or posterior cross vein 
(ACV) with the campaniform sensillae shown by an arrow. Note the missing anterior 
cross vein in panel G (dpp-Gal4 driver), partial anterior cross vein and abnormal 
posterior cross vein in panel J (en-Gal4 driver), the relocation of the companiform 
sensillae from the anterior cross vein to the longitudinal vein in panel J.	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bristle loss does not appear to be intrinsic to development — as a control we found 
no sex difference in bristle loss in the classic developmental mutant Scutoid (Sco) (FUSE 
et al. 1999), which suppresses notum bristles to approximately the same extent as 
mutant hINS expression, but does so to equal extent in both sexes (Table S7).  
 
     Expression of mutant (but not wild type) hINS in the developing wing imaginal disc 
causes visible defects in a proportion of adult wings (Figure 3 E-O). dpp-Gal4 drives 
expression in cells adjacent to the border of the posterior and anterior wing 
compartments; en-Gal4 drives expression only in the posterior wing compartment. In 
dpp-Gal4 / UAS-hINSC96Y flies, the distal margin of approximately 30% of wings are 
either scalloped or the anterior crossvein (ACV) absent, both phenotypes being 
restricted to the domain where mutant insulin is predicted to be expressed. Expression 
of mutant hINS by the en-Gal4 driver results in occasional partial loss of ACV along its 
posterior boundary, also corresponding to the predicted region of mutant protein 
expression. 
Wing scalloping and ACV loss are striking phenocopies of the classical mutants 
Notch (incision of wing margin) and crossveinless, respectively, both regulators of wing 
development. Portions of the adult wing corresponding to mutant hINS expression in the 
wing imaginal disc are also significantly reduced in area (Figure 4).  
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Figure 4 Effect of hINSC96Y expression on female wing development. (A) Regions of en 
(red) and dpp (blue) expression. (C) en (genotype):  en-Gal4 (n=13); en-Ga4 / UAS-
hINSWT (n=13); and en-Gal4 / UAS-hINSC96Y (n=13). The values represent the ratio of 
the posterior wing compartment divided by the total wing area. (C) dpp (genotype): dpp-
Gal4 (n=10), dpp-Gal4 / UAS-hINSWT ( n=10), and dpp-Gal4 / UAS-hINSC96Y (n=11) . 
The values represent the ratio of the L3-L4 intervein sector divided by the L2-L4 
intervein sector area. NS, not significant Mann-Whitney U Test.	  	  
Mechano-sensory structures on the wing — the campaniform sensillae — can also 
be absent in portions of the wing where mutant hINS is expressed under the control of 
	  	   23	  
the dpp- and en-drivers (Figure S5). One such sensilla lies along anterior portion of 
ACV, and is typically absent when that portion of the crossvein is missing in en-Gal4 / 
UAS-hINSC96Y flies. In dpp-Gal4 / UAS-hINSC96Y flies, three additional sensillae sitting 
along the distal portion of the longitudinal wing vein 3, can also be absent (Table S8).  
Mutant proinsulin expression in the developing wing also causes misspecification of 
cell fates to produce both ectopic wing veins and campaniform sensillae. The en-Gal4 
driver, in particular, produces the novel appearance of both veins and sensillae (Figure 
3 M, O). A sensilla sitting along the ACV, when absent in en-Gal4 / UAS-hINSC96Y wings, 
is often replaced with an ectopic one appearing more anteriorly along the ACV, or along 
the radial wing vein proximal to where it is intersected by the ACV. The posterior wing 
crossvein in the mutant can also project ectopic longitudinal veins.  	  
hINSC96Y induced phenotypes are modified by genetic background	  
The eye, wing and notum are notable examples of developmentally canalized structures 
that generally become more variable in a mutant background. Consistent with this 
observation, the mutant hINS-induced eye phenotype displays sensitivity to temperature 
and differs between the two sexes. In crosses involving the 3rd chromosome balancer 
TM3, we also observed more severe eye phenotypes when the balancer chromosome 
was present (CARL 2010), indicating sensitivity to the genetic background. We therefore 
examined the extent to which naturally occurring genetic variation modifies the mutant 
hINS phenotype in the eye and notum. We crossed a “tester” stock carrying the mutant 
transgene (M-1) and either the GMR-Gal4 or ap-Gal4 driver on the same 2nd 
chromosome (GMR>>hINSC96Y or ap>>hINSC96Y) with 38 reference inbred lines derived 
from a single population collection, the DGRP (MACKAY et al. 2012) and measured eye 
phenotypes or counted dorsal macrochaetae in F1 adults. The F1 males in the crosses 
carried an identical X-chromosome — the tester chromosome. The screen, therefore, 
revealed only partially- or fully-dominant autosomal modifiers of the mutant phenotype. 
For each cross we measured eye area or dorsal bristle number in a minimum of 10 
individuals of each sex.	  
Eye phenotypes: The crosses revealed highly heritable genetic variation (h2 (males) 
= 0.732; h2 (females) = 0.657), visible as a nearly continuous distribution of between-
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line differences in eye degeneration phenotypes ranging from nearly wild type to highly 
reduced and slit-like eyes (Figure 5 A, C). These inter-line differences are not correlated 
with either each line’s body size (bi-variate fit of eye area with thorax length r2= 0.0051 
(CARL 2010)) or eye area (Figure S6), nor with the quantity of Gal4 protein, which did 
not vary significantly (Figure S7). There are also significant between-line differences in 
other aspects of the eye phenotype, including aspect ratio (width:height), ommatidial 
degeneration, and prevalence of lesions (CARL 2010). Lesion prevalence, unlike aspect 
ratio or ommatidial degeneration, was not significantly correlated with the extent of eye 
loss (r2 = 0.01), indicating the two have independent genetic underpinnings rather than 
being the consequence of pleiotropy.	  
	  
Figure 5 Genetic variation for hINSC96Y-induced degeneration in the adult eye and 
notum. (A) Variation in eye area in F1 adults from crosses between GMR>>hINSC96Y 
tester strain and 38 DGRP lines described in Materials and Methods. (B) Bristle number 
in F1 adults from crosses in (A). (C and D) Eye area and bristle number. The data are 
displayed from left to right by decreasing severity of phenotypes. Eye area (mean ± SE) 
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for a wild type control (GMR-Gal4) is shown on the far right in filled circles (in C, only 
male wild type eye areas are shown). (E) Correlation between bristle loss and eye-area 
reduction (male: Spearman's rank correlation rho = -0.23, P = 0.16; female: rho = -0.17, 
P = 0.30).  	  
Notum phenotypes: As with the eye phenotype, we found significant inter-line 
variation ranging from lines with nearly wild type bristle number (RAL-427, bristle 
reduction = 0.44 ± 0.65) to ones missing a majority of bristles (RAL-335, bristle 
reduction = 15.04 ± 1.10) and a high heritability (h2 (males)=0.744).	  
 
Disease traits are uncorrelated 	  
We reasoned that if the genetic pathways responding to hINSC96Y expression common 
to both eye and notum, such as UPR, harbor modifiers of the response, then the 
severity of the eye reduction and bristle loss should be positively correlated in the 
sample of DGRP lines. To ask whether the same modifiers are acting in similar manner 
in both tissues we measured the correlation between traits in the 38 lines for which both 
were measured. Surprisingly, we found no evidence for a positive correlation (Figure 5E; 
Table S9; Male: Spearman's rank correlation rho = -0.23, P = 0.16; Female: rho = -0.17, 
P = 0.30). The common response pathways either harbor little of the genetic variation 
for the disease phenotypes, or their penetrance must be modulated by tissue-specific 
factors.	  	  
Variation in eye-specific genetic pathways is uncorrelated with hINSC96Y–induced 
phenotypes	  
The lack of correlated mutant hINS induced phenotypes in the eye and notum raises an 
alternative possibility that genetic variation acts not through shared response pathways 
but rather through tissue-specific developmental pathways, and in so doing “releases” 
pathway-specific genetic variation otherwise suppressed in the wild type. To test this 
possibility, we examined genetic variation in the DGRP lines for two eye-development-
specific genetic mutations Lobe (L) and Drop (Dr). L and Dr are classic dominant eye-
degeneration mutations that can be crossed to the DGRP lines in the same manner as 
the mutant insulin transgene to reveal dominant genetic variation for reduced-eye 
phenotypes. L encodes the ortholog of mammalian PRAS40 and regulates eye 
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development through TORC1 signaling (WANG and HUANG 2009); mutants display an 
apoptotic reduced-eye phenotype. L acts through the Jak/Stat signaling pathway in the 
ventral eye, possibly interacting with the Notch ligand, Serrate (CHERN and CHOI 2002). 
Dr, in contrast, is a muscle segment homeobox-1 transcription factor that regulates 
interaction between epithelial and mesenchymal cells. It is active in embryonic neural 
dorsal-ventral patterning and again in eye development. Dr mutants ectopically express 
the muscle segment homeobox (msh) gene, blocking morphogenetic furrow progression 
in the developing eye, leading to apoptotic photoreceptor cell loss and a nearly eyeless 
phenotype (MOZER 2001). 	  
The genetic variation exposed by mutant hINS expression appears to be distinct 
from the genetic variation exposed by eye development mutants despite its apparent 
tissue specificity. We crossed L, Dr and hINSC96Y to 38 DGRP lines and collected F1 
adults for eye area measurement. Variation in hINSC96Y-induced eye degeneration was 
comparable to previous measurements in the same lines (Figure 6A, D; Figures S1, S8; 
Table S10, S11). F1 flies displayed heritable variation for both Dr and L phenotypes, 
which when scaled by their within-line variances displayed a range of phenotypes 
similar to hINSC96Y flies (Figure 6A, C). There is no significant correlation between any 
pair of traits (Figure 6C; Table S9), and thus no evidence for shared variation acting on 
mutant hINS and two eye development specific mutants. It is also worth noting that for 
both L and Dr, eye area in males is approximately 85% that of females, consistent with 
the difference in wild type flies. In contrast, eye area in males of mutant insulin-
expressing crosses is 50% that of females, indicating a sex-specific input to the disease 
phenotype (also see Figures 5C and D). 
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Figure 6 Genetic variation for eye area reduction in F1 adults from crosses between 
GMR>>hINSC96Y, Drop, or Lobe and 38 DGRP lines. (A) Range of phenotypes in F1 
adults in both sexes. (B) Deviation (in units of within-line SD) of each line mean from the 
overall mean within each of the three sets of crosses. (C) Correlation of eye area 
reduction between hINSC96Y and Dr (open circle) or L (closed circle) x DGRP F1 males. 
(D) Boxplots showing the unscaled distribution of phenotypes in the three sets of crosses 
(thick line: median; box: 25th and 75th percentile; whisker: 1.5 interquartile range (IQR); 
circles: data outside the 1.5 IQR).	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DISCUSSION	  
Drosophila is a useful model for studying cell function and development in response to 
misfolded proinsulin. We show that mutant (but not wild type) hINS expression causes a 
reduction in size (and cell number for eyes) in every tissue examined. Human proinsulin 
is not processed to insulin in developing eye cells, but can be induced to do so by 
overexpressing a secretory cell master regulator, the bHLH transcription factor DIMMED 
(PARK et al. 2012). Consistent with this result, we observed no effect of wild type hINS 
expression on gene expression or eye development. Although we have not established 
specific mechanism(s) by which mutant-induced eye reduction occurs, one of them is 
likely to involve UPR, which we show is induced based on both the presence of Xbp1 
alternatively spliced mRNA in eye imaginal discs expressing hINSC96Y, and on the 
induction of well-known stress response genes, including ones aiding protein folding 
and promoting programmed cell death. We also establish a reorganization of gene 
expression in imaginal disc cells in response to mutant hINS expression.	  
Cell death in the Drosophila model recapitulates a key feature of disease observed 
in mouse diabetes caused by the same C96Y mutation in Ins2: the dominant loss of 
insulin-secreting beta cells (KAYO and KOIZUMI 1998; WANG et al. 1999). In the mouse 
model, the synthesis of misfolded proinsulin leads to its retention in the ER resulting in 
induction of UPR, death of the insulin-secreting pancreatic beta cells, and diabetes 
(SONG et al. 2008; TABAS and RON 2011). The human form of hINSC96Y-induced disease 
is believed to act through the same mechanism (LIU et al. 2010; PARK et al. 2010); 
based on our gene expression experiment, this may hold true in the Drosophila model 
as well.	  
Developing tissues, we discovered, are more sensitive to mutant hINS expression 
in males than females. When expressed in the eye, hINSC96Y causes a nearly two-fold 
reduction in eye area in males compared to females. Other features of the eye, 
including the presence of necrotic lesions, photoreceptor cell collapse, and ommatidial 
disorganization, are also more evident in males. L and Dr in contrast, although also 
producing reduced-eye phenotypes, do not exhibit sex-specific differences relative to 
wild type. The flexibility of the Drosophila model allowed us to establish that the notum 
also displays a differential male sensitivity to mutant hINS expression. We believe, 
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therefore, that the greater sensitivity to mutant hINS in males must involve cell 
physiology rather than tissue-specific development. We can entertain at least two 
hypotheses for the male sensitivity, both of which are potentially testable. One obvious 
possibility involves disruption of dosage compensation. In Drosophila, dosage 
compensation occurs in males by up-regulating X-linked genes through the activity of 
the male sex lethal (MSL) complex (GELBART and KURODA 2009). Reorganization of 
gene expression in stressed cells may disrupt maintenance of dosage compensation, 
leading to the exacerbation of cellular stress and cell death in males. An alternative 
hypothesis posits that cells in males are less well canalized against perturbation, such 
as with expression of mutant hINS, perhaps because dosage compensation introduces 
greater variability in X-linked gene expression. It is well known, for example, that the 
effectiveness of dosage compensation varies quantitatively across X-linked genes and 
is complete in only a subset of them (HAMADA et al. 2005). Cell-to-cell or temporal 
variation in X-linked gene expression might increase demand on the homeostatic 
mechanisms involving proteostasis. It should be possible to test these hypotheses by 
genetically manipulating flies to examine sex determination, dosage compensation, or 
sex differentiation pathway contributions to male biased disease. More generally, fly 
models of human disease, such as ours, may be valuable in disentangling 
environmental and genetic contributions to sex differences in susceptibility or severity of 
disease, a notoriously difficult problem in human studies.	  
Male sex bias may be a general property of the disease: it is also a feature of 
diabetes in mice (WANG et al. 1999). Male mice heterozygous for Ins2C96Y develop 
diabetes at an earlier age than females (OYADOMARI et al. 2002). In the fly, X-linked 
genes are up-regulated in males whereas in mammals a single X-chromosome is 
inactivated in females cells. If the mechanism underlying the male bias in fly and mouse 
is the same, it is unlikely, therefore, to directly involve dosage compensation.	  
A second unexpected finding was the presence of fully differentiated ectopic veins 
and sensory structures in wings expressing mutant hINS. These same wings also 
display loss-of-structure phenotypes, including crossveins and campaniform sensillae, 
as well as scalloping of wing margins. Both ectopic gain and loss of these differentiated 
tissues are striking phenocopies of classical wing mutations, many of which have been 
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shown to be involved in the regulation of wing development (NETO-SILVA et al. 2009). 
We believe, therefore, that mutant hINS expression can not only induce cell death, but 
can also lead to reprogramming of cell fates. An interesting implication for the human 
form of the disease is that loss of beta cells in neonates may involve not only cell death 
but also transformation of precursor cells to other cell types. 	  
Third, crosses to a reference panel of naturally derived lines (DGRP) revealed 
extensive dominant (or partially-dominant) genetic variation acting to suppress or 
enhance cell loss. One possibility, which we investigated and could reject, is variation in 
mutant hINS gene expression in different DGRP backgrounds. Since all the flies carry 
the same tester chromosome, (GMR>>hINSC96Y), we focused our attention on Gal4 
instead, because its expression could be influenced by variation in transcription factors 
acting on its promoter, GMR; we found no evidence for differences in Gal4 protein 
levels between DGRP lines representative of the full range of eye degeneration 
phenotypes (Figure S7). GMR is a synthetic enhancer consisting of binding sites for the 
eye-specific transcription factor Glass (Gl). In an accompanying paper, we also find no 
evidence for association of genetic variation in or around the Gl locus with eye 
degeneration (HE et al. 2013). We do not believe, therefore, that variation in eye 
degeneration is caused by genetic variation in the transcription of mutant hINS.	  
Finding extensive genetic variation in eye degeneration in our F1 screen establishes 
the feasibility of applying methods of statistical association to identify modifiers of 
disease, the subject of the accompanying paper (HE et al. 2013). Here we explored 
other dimensions of this variability. It is worth noting that many, if not most, Mendelian 
models of disease in the fly involve gain-of-function alleles, which facilitates screens for 
natural variation in F1 flies. In additional to the convenience of this genetic screen, it 
also eliminates phenotypes resulting from the homozygosity of deleterious alleles in 
inbred lines. Outcrossed genotypes are well suited for investigating low frequency 
variants, which are rarely homozygous in natural populations. 	  
Disease phenotypes in the eye and notum were not significantly correlated in the 
DGRP panel, suggesting that different suites of alleles are acting in the two tissues. A 
positive correlation would be expected if genetic variation occurred primarily in shared 
pathways responding to mutant hINS expression, such as UPR. Not finding evidence for 
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such a correlation, we then investigated whether a correlation would be observed 
comparing a single phenotype — eye reduction — caused by hINS and by two classical 
mutations. The fact that we failed to find significant correlations between either L or Dr 
and hINSC96Y leaves us with a puzzling set of results: natural variation for hINS-induced 
disease severity exhibits tissue specificity but involves a different set of genes or alleles 
than ones revealed with eye-development-specific mutants. The latter result, but 
perhaps not the former, should come as no surprise. In other models of Mendelian 
disease, e.g. aggregation-prone proteins expressed in the developing eye, forward 
genetic screens for suppressors and enhancers of reduced eye phenotypes 
successfully identify genes acting in pathways known to be responsive to proteostatic 
stress, UPR, apoptosis, RNA-folding, and peptide folding, transit, and degradation 
pathways (CHAI et al. 1999; WARRICK et al. 1999; CHAN et al. 2000; CHAN and BONINI 
2003; BILEN and BONINI 2005; WARRICK et al. 2005; BILEN and BONINI 2007; LESSING and 
BONINI 2008; LI et al. 2008; YU and BONINI 2011), but not regulators of eye development. 
As this also appears to be the case for naturally occurring variation in our Mendelian 
model of disease, distinct alleles and genes must be acting as modifiers, perhaps 
epistatically, in different tissues. 	  
An alternative hypothesis can be constructed on the premise that the spectrum of 
mutations affecting this complex disease trait may have a much broader set of targets, 
needing only to impinge on processes involved in cellular or physiological homeostasis. 
Disease occurs when an individual’s homeostatic “capacitance” – the ability to buffer 
against cellular stress – is exceeded. Whether a threshold is crossed will depend on 
both the cellular activities set by an individual’s background genotype and on 
environmental demands or rare mutant alleles acting in critical pathways. 	  
Subtle effects of genetic background on the ability of a cell to balance protein 
synthesis, folding, transport, and degradation —i.e., proteostasis — may be responsible 
for many diseases, in addition to diabetes. Under this hypothesis, a complex and diffuse 
web of interacting polymorphisms set an individual’s ability to respond to genetic or 
environmental challenges, determining susceptibility to and severity of disease. If true, 
the vast majority of mutations and the spectrum of disease-causing loci segregating in 
natural populations are likely to be systematically and substantially different than the 
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strong loss- or gain-of-function alleles identified in forward genetic screens alone. 	  
In addition, as proteomes differ between tissues, so too will the alleles affecting 
proteostasis. This possibility is illustrated by revealing experiments on two aggregation-
prone / misfolded proteins in a worm model: polyglutamine protein ((GIDALEVITZ et al. 
2006) and mutant SOD1 (GIDALEVITZ et al. 2009). In both cases, temperature sensitive 
(ts) mutations in housekeeping proteins, although innocuous when the worm is reared 
below the ts threshold, enhance mutant protein phenotypes, and hence toxicity, when 
the ts threshold is exceeded. SOD1 phenotypes are also sensitive to the genetic 
background. 	  
Drosophila is an excellent model for investigating naturally occurring genetic 
variation for quantitative traits. The recent establishment of the DGRP (MACKAY et al. 
2012), synthetic populations (HUANG et al. 2012; KING et al. 2012), and other novel 
population resequencing approaches (TURNER and MILLER 2012), add to its power and 
appeal. Here we extend the applicability of these approaches to the study of human 
disease. An important question remaining to be addressed is whether the extensive 
genetic variation revealed in this study of a genetically “sensitized” fly is the same as the 
variation underlying complex genetic forms of the disease, an issue further discussed in 
the accompanying paper. Affirmative answer to this question raises the prospect for 
using Drosophila as a model of genetically complex human disease.	  	  
ACKNOWLEDGMENTS	  
This work was funded by grants from the National Institute of Diabetes and Digestive 
and Kidney Diseases (R01DK013914 and P30DK020595), the National Institute of 
General Medical Sciences (P50GM081892), the Chicago Biomedical Consortium with 
support from the Searle Funds at The Chicago Community Trust, and a gift from the 
Kovler Family Foundation. We thank Honggang Ye, Esme Gaisford, Amanda Neisch, 
Richard Morimoto, Ilya Ruvinsky, Richard Hudson, Rick Fehon and Ilaria Rebay for 
technical help and advice. The content is solely the responsibility of the authors and 
does not necessarily represent the official views of the National Institute of Diabetes and 
Digestive and Kidney Diseases, the National Institute of General Medical Sciences or 
the National Institutes of Health.	  
	  	   33	  
LITERATURE CITED	  
AYROLES, J. F., M. A. CARBONE, E. A. STONE, K. W. JORDAN, R. F. LYMAN et al., 2009 
Systems genetics of complex traits in Drosophila melanogaster. Nat Genet 41: 
299-307.	  
BEDELL, M. A., N. A. JENKINS and N. G. COPELAND, 1997a Mouse models of human 
disease. Part I: techniques and resources for genetic analysis in mice. Genes 
Dev 11: 1-10.	  
BEDELL, M. A., D. A. LARGAESPADA, N. A. JENKINS and N. G. COPELAND, 1997b Mouse 
models of human disease. Part II: recent progress and future directions. Genes 
Dev 11: 11-43.	  
BELL, G. I., W. F. SWAIN, R. PICTET, B. CORDELL, H. M. GOODMAN et al., 1979 Nucleotide 
sequence of a cDNA clone encoding human preproinsulin. Nature 282: 525-527.	  
BENJAMINI, Y., and D. YEKUTIELI, 2001 The control of the false discovery rate in multiple 
testing under dependency. Annals of Statistics 29: 1165-1188.	  
BERGLAND, A. O., A. GENISSEL, S. V. NUZHDIN and M. TATAR, 2008 Quantitative trait loci 
affecting phenotypic plasticity and the allometric relationship of ovariole number 
and thorax length in Drosophila melanogaster. Genetics 180: 567-582.	  
BILEN, J., and N. M. BONINI, 2005 Drosophila as a model for human neurodegenerative 
disease. Annual Review of Genetics 39: 153-171.	  
BILEN, J., and N. M. BONINI, 2007 Genome-wide screen for modifiers of ataxin-3 
neurodegeneration in Drosophila. PLoS Genet 3: 1950-1964.	  
BITEAU, B., J. KARPAC, D. HWANGBO and H. JASPER, 2011 Regulation of Drosophila 
lifespan by JNK signaling. Exp Gerontol 46: 349-354.	  
CARL, S. H., 2010 Naturally occurring genetic variation influences the severity of 
Drosophila eye degeneration induced by expression of a mutant human insulin 
gene. Undergraduate thesis, University of Chicago.	  
CHAI, Y., S. L. KOPPENHAFER, N. M. BONINI and H. L. PAULSON, 1999 Analysis of the role 
of heat shock protein (Hsp) molecular chaperones in polyglutamine disease. J 
Neurosci 19: 10338-10347.	  
CHAN, H. Y., and N. M. BONINI, 2003 Drosophila models of polyglutamine diseases. 
Methods Mol Biol 217: 241-251.	  
	  	   34	  
CHAN, H. Y., J. M. WARRICK, G. L. GRAY-BOARD, H. L. PAULSON and N. M. BONINI, 2000 
Mechanisms of chaperone suppression of polyglutamine disease: selectivity, 
synergy and modulation of protein solubility in Drosophila. Hum Mol Genet 9: 
2811-2820.	  
CHERN, J. J., and K. W. CHOI, 2002 Lobe mediates Notch signaling to control domain-
specific growth in the Drosophila eye disc. Development 129: 4005-4013.	  
CHINTAPALLI, V. R., J. WANG and J. A. DOW, 2007 Using FlyAtlas to identify better 
Drosophila melanogaster models of human disease. Nat Genet 39: 715-720.	  
COX, J. S., and P. WALTER, 1996 A novel mechanism for regulating activity of a 
transcription factor that controls the unfolded protein response. Cell 87: 391-404.	  
DWORKIN, I., and G. GIBSON, 2006 Epidermal growth factor receptor and transforming 
growth factor-beta signaling contributes to variation for wing shape in Drosophila 
melanogaster. Genetics 173: 1417-1431.	  
DWORKIN, I., E. KENNERLY, D. TACK, J. HUTCHINSON, J. BROWN et al., 2009 Genomic 
consequences of background effects on scalloped mutant expressivity in the 
wing of Drosophila melanogaster. Genetics 181: 1065-1076.	  
FREEMAN, M., 1996 Reiterative use of the EGF receptor triggers differentiation of all cell 
types in the Drosophila eye. Cell 87: 651-660.	  
FUSE, N., H. MATAKATSU, M. TANIGUCHI and S. HAYASHI, 1999 Snail-type zinc finger 
proteins prevent neurogenesis in Scutoid and transgenic animals of Drosophila. 
Dev Genes Evol 209: 573-580.	  
GELBART, M. E., and M. I. KURODA, 2009 Drosophila dosage compensation: a complex 
voyage to the X chromosome. Development 136: 1399-1410.	  
GEMINARD, C., E. J. RULIFSON and P. LEOPOLD, 2009 Remote control of insulin secretion 
by fat cells in Drosophila. Cell Metab 10: 199-207.	  
GIBSON, G., and L. K. REED, 2008 Cryptic genetic variation. Curr Biol 18: R989-990.	  
GIDALEVITZ, T., A. BEN-ZVI, K. H. HO, H. R. BRIGNULL and R. I. MORIMOTO, 2006 
Progressive disruption of cellular protein folding in models of polyglutamine 
diseases. Science 311: 1471-1474.	  
GIDALEVITZ, T., T. KRUPINSKI, S. GARCIA and R. I. MORIMOTO, 2009 Destabilizing protein 
polymorphisms in the genetic background direct phenotypic expression of mutant 
	  	   35	  
SOD1 toxicity. PLoS Genet 5: e1000399.	  
GOERING, L. M., P. K. HUNT, C. HEIGHINGTON, C. BUSICK, P. S. PENNINGS et al., 2009 
Association of orthodenticle with natural variation for early embryonic patterning 
in Drosophila melanogaster. J Exp Zool B Mol Dev Evol 312: 841-854.	  
HAMADA, F. N., P. J. PARK, P. R. GORDADZE and M. I. KURODA, 2005 Global regulation of 
X chromosomal genes by the MSL complex in Drosophila melanogaster. Genes 
Dev 19: 2289-2294.	  
HARTLEY, T., M. SIVA, E. LAI, T. TEODORO, L. ZHANG et al., 2010 Endoplasmic reticulum 
stress response in an INS-1 pancreatic beta-cell line with inducible expression of 
a folding-deficient proinsulin. BMC Cell Biol 11: 59.	  
HASELTON, A. T., and Y. W. FRIDELL, 2010 Adult Drosophila melanogaster as a model for 
the study of glucose homeostasis. Aging (Albany NY) 2: 523-526.	  
HE, B., M. Z. LUDWIG, S. Y. PARK, N. A. TAMARINA, et al., 2013 A Drosophila model to 
investigate natural variation effect in response to expression of a human 
misfolded protein. Genetics.	  
HOCHBERG, Y., and Y. BENJAMINI, 1990 More powerful procedures for multiple 
significance testing. Stat Med 9: 811-818.	  
HUANG, W., S. RICHARDS, M. A. CARBONE, D. ZHU, R. R. ANHOLT et al., 2012 Epistasis 
dominates the genetic architecture of Drosophila quantitative traits. Proc Natl 
Acad Sci U S A 109: 15553-15559.	  
KANG, M. J., J. CHUNG and H. D. RYOO, 2012 CDK5 and MEKK1 mediate pro-apoptotic 
signalling following endoplasmic reticulum stress in an autosomal dominant 
retinitis pigmentosa model. Nat Cell Biol 14: 409-415.	  
KANG, M. J., and H. D. RYOO, 2009 Suppression of retinal degeneration in Drosophila by 
stimulation of ER-associated degradation. Proc Natl Acad Sci U S A 106: 17043-
17048.	  
KARPAC, J., and H. JASPER, 2009 Insulin and JNK: optimizing metabolic homeostasis 
and lifespan. Trends Endocrinol Metab 20: 100-106.	  
KING, E. G., C. M. MERKES, C. L. MCNEIL, S. R. HOOFER, S. SEN et al., 2012 Genetic 
Dissection of a Model Complex Trait Using the Drosophila Synthetic Population 
Resource. Genome Res 22:1558-1566. 
	  	   36	  
LESSING, D., and N. M. BONINI, 2008 Polyglutamine genes interact to modulate the 
severity and progression of neurodegeneration in Drosophila. PLoS Biol 6: e29.	  
LESSING, D., and N. M. BONINI, 2009 Maintaining the brain: insight into human 
neurodegeneration from Drosophila melanogaster mutants. Nat Rev Genet 10: 
359-370.	  
LI, L. B., Z. YU, X. TENG and N. M. BONINI, 2008 RNA toxicity is a component of ataxin-3 
degeneration in Drosophila. Nature 453: 1107-1111.	  
LIESCHKE, G. J., and P. D. CURRIE, 2007 Animal models of human disease: zebrafish 
swim into view. Nat Rev Genet 8: 353-367.	  
LIU, M., L. HAATAJA, J. WRIGHT, N. P. WICKRAMASINGHE, Q. X. HUA et al., 2010 Mutant 
INS-gene induced diabetes of youth: proinsulin cysteine residues impose 
dominant-negative inhibition on wild-type proinsulin transport. PLoS One 5: 
e13333.	  
LUDWIG, M. Z., N. A. TAMARINA and R. C. RICHMOND, 1993 Localization of sequences 
controlling the spatial, temporal, and sex-specific expression of the esterase 6 
locus in Drosophila melanogaster adults. Proc Natl Acad Sci U S A 90: 6233-
6237.	  
MACKAY, T. F., 2010 Mutations and quantitative genetic variation: lessons from 
Drosophila. Philos Trans R Soc Lond B Biol Sci 365: 1229-1239.	  
MACKAY, T. F., 2011 Evolutionary genetics quantified. Nat Genet 42: 1033.	  
MACKAY, T. F., S. RICHARDS, E. A. STONE, A. BARBADILLA, J. F. AYROLES et al., 2012 The 
Drosophila melanogaster Genetic Reference Panel. Nature 482: 173-178.	  
MACKAY, T. F., E. A. STONE and J. F. AYROLES, 2009 The genetics of quantitative traits: 
challenges and prospects. Nat Rev Genet 10: 565-577.	  
MENDES, C. S., C. LEVET, G. CHATELAIN, P. DOURLEN, A. FOUILLET et al., 2009 ER stress 
protects from retinal degeneration. EMBO J 28: 1296-1307.	  
MORI, K., N. OGAWA, T. KAWAHARA, H. YANAGI and T. YURA, 2000 mRNA splicing-
mediated C-terminal replacement of transcription factor Hac1p is required for 
efficient activation of the unfolded protein response. Proc Natl Acad Sci U S A 97: 
4660-4665.	  
MOZER, B. A., 2001 Dominant Drop mutants are gain-of-function alleles of the muscle 
	  	   37	  
segment homeobox gene (msh) whose overexpression leads to the arrest of eye 
development. Dev Biol 233: 380-393.	  
NETO-SILVA, R. M., B. S. WELLS and L. A. JOHNSTON, 2009 Mechanisms of growth and 
homeostasis in the Drosophila wing. Annu Rev Cell Dev Biol 25: 197-220.	  
OCORR, K. A., T. CRAWLEY, G. GIBSON and R. BODMER, 2007 Genetic variation for 
cardiac dysfunction in Drosophila. PLoS One 2: e601.	  
OYADOMARI, S., A. KOIZUMI, K. TAKEDA, T. GOTOH, S. AKIRA et al., 2002 Targeted 
disruption of the Chop gene delays endoplasmic reticulum stress-mediated 
diabetes. J Clin Invest 109: 525-532.	  
PALSSON, A., and G. GIBSON, 2004 Association between nucleotide variation in Egfr and 
wing shape in Drosophila melanogaster. Genetics 167: 1187-1198.	  
PANDEY, U. B., and C. D. NICHOLS, 2011 Human disease models in Drosophila 
melanogaster and the role of the fly in therapeutic drug discovery. Pharmacol 
Rev 63: 411-436.	  
PARK, D., X. HOU, J. V. SWEEDLER and P. H. TAGHERT, 2012 Therapeutic peptide 
production in Drosophila. Peptides 36: 251-256.	  
PARK, S. Y., H. YE, D. F. STEINER and G. I. BELL, 2010 Mutant proinsulin proteins 
associated with neonatal diabetes are retained in the endoplasmic reticulum and 
not efficiently secreted. Biochem Biophys Res Commun 391: 1449-1454.	  
PASSADOR-GURGEL, G., W. P. HSIEH, P. HUNT, N. DEIGHTON and G. GIBSON, 2007 
Quantitative trait transcripts for nicotine resistance in Drosophila melanogaster. 
Nat Genet 39: 264-268.	  
ROBINOW, S., and K. WHITE, 1991 Characterization and spatial distribution of the ELAV 
protein during Drosophila melanogaster development. J Neurobiol 22: 443-461.	  
RUDRAPATNA, V. A., R. L. CAGAN and T. K. DAS, 2012 Drosophila cancer models. Dev 
Dyn 241: 107-118.	  
RYOO, H. D., P. M. DOMINGOS, M. J. KANG and H. STELLER, 2007 Unfolded protein 
response in a Drosophila model for retinal degeneration. EMBO J 26: 242-252.	  
SCHEUNER, D., and R. J. KAUFMAN, 2008 The unfolded protein response: a pathway that 
links insulin demand with beta-cell failure and diabetes. Endocr Rev 29: 317-333.	  
SCHLEGEL, A., and D. Y. STAINIER, 2007 Lessons from "lower" organisms: what worms, 
	  	   38	  
flies, and zebrafish can teach us about human energy metabolism. PLoS Genet 3: 
e199.	  
SHEN, X., R. E. ELLIS, K. LEE, C. Y. LIU, K. YANG et al., 2001 Complementary signaling 
pathways regulate the unfolded protein response and are required for C. elegans 
development. Cell 107: 893-903.	  
SONG, B., D. SCHEUNER, D. RON, S. PENNATHUR and R. J. KAUFMAN, 2008 Chop deletion 
reduces oxidative stress, improves beta cell function, and promotes cell survival 
in multiple mouse models of diabetes. J Clin Invest 118: 3378-3389.	  
SPRADLING, A. C., D. M. STERN, I. KISS, J. ROOTE, T. LAVERTY et al., 1995 Gene 
disruptions using P transposable elements: an integral component of the 
Drosophila genome project. Proc Natl Acad Sci U S A 92: 10824-10830.	  
ST JOHNSTON, D., 2002 The art and design of genetic screens: Drosophila melanogaster. 
Nat Rev Genet 3: 176-188.	  
STOY, J., E. L. EDGHILL, S. E. FLANAGAN, H. YE, V. P. PAZ et al., 2007 Insulin gene 
mutations as a cause of permanent neonatal diabetes. Proc Natl Acad Sci U S A 
104: 15040-15044.	  
STOY, J., D. F. STEINER, S. Y. PARK, H. YE, L. H. PHILIPSON et al., 2010 Clinical and 
molecular genetics of neonatal diabetes due to mutations in the insulin gene. Rev 
Endocr Metab Disord 11: 205-215.	  
TABAS, I., and D. RON, 2011 Integrating the mechanisms of apoptosis induced by 
endoplasmic reticulum stress. Nat Cell Biol 13: 184-190.	  
TANEERA, J., S. LANG, A. SHARMA, J. FADISTA, Y. D. ZHOU et al., 2012 A Systems 
Genetics Approach Identifies Genes and Pathways for Type 2 Diabetes in 
Human Islets. Cell Metabolism 16: 122-134.	  
TELONIS-SCOTT, M., L. M. MCINTYRE and M. L. WAYNE, 2005 Genetic architecture of two 
fitness-related traits in Drosophila melanogaster: ovariole number and thorax 
length. Genetica 125: 211-222.	  
TURNER, T. L., and P. M. MILLER, 2012 Investigating natural variation in Drosophila 
courtship song by the evolve and resequence approach. Genetics 191: 633-642.	  
WANG, J., T. TAKEUCHI, S. TANAKA, S. K. KUBO, T. KAYO et al., 1999 A mutation in the 
insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in 
	  	   39	  
the Mody mouse. J Clin Invest 103: 27-37.	  
WANG, M. H., L. G. HARSHMAN and S. V. NUZHDIN, 2005 Quantitative trait loci for lipid 
content in Drosophila melanogaster. Obes Res 13: 1891-1897.	  
WANG, Y., D. POT, S. D. KACHMAN, S. V. NUZHDIN and L. G. HARSHMAN, 2006 A 
quantitative trait locus analysis of natural genetic variation for Drosophila 
melanogaster oxidative stress survival. J Hered 97: 355-366.	  
WANG, Y. H., and M. L. HUANG, 2009 Reduction of Lobe leads to TORC1 hypoactivation 
that induces ectopic Jak/STAT signaling to impair Drosophila eye development. 
Mech Dev 126: 781-790.	  
WARRICK, J. M., H. Y. CHAN, G. L. GRAY-BOARD, Y. CHAI, H. L. PAULSON et al., 1999 
Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the 
molecular chaperone HSP70. Nat Genet 23: 425-428.	  
WARRICK, J. M., L. M. MORABITO, J. BILEN, B. GORDESKY-GOLD, L. Z. FAUST et al., 2005 
Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a 
ubiquitin-associated mechanism. Mol Cell 18: 37-48.	  
YOSHIDA, H., T. MATSUI, A. YAMAMOTO, T. OKADA and K. MORI, 2001 XBP1 mRNA is 
induced by ATF6 and spliced by IRE1 in response to ER stress to produce a 
highly active transcription factor. Cell 107: 881-891.	  
YU, Z., and N. M. BONINI, 2011 Modeling human trinucleotide repeat diseases in 
Drosophila. Int Rev Neurobiol 99: 191-212.	  	  
                    
 
 
 
 
 
 
                   
	  	   40	  
                SUPPLEMENTARY FIGURES  
	  
Figure S1 Correlation of GMR>>hINSC96Y eye phenotypes in crosses to DGRP lines. 
Shown are data collected in two independent experiments carried out in 2009 and 2011. 
Plotted are average eye areas for approximately 10 males, as described in the Materials 
& Methods. 	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Figure S2 Bristle count. Notum bristles (macrochaete). (A) Wild type female. (B), (C) 
Notum of Sco mutant (w1118; CyO dfd-YFP / snaSco); (B) female; (C) male. (D) 
Macrochaete positions on heminotum and humerus with their nomenclature.  aDC, 
anterior dorsocentral bristle; aNP, anterior notopleural bristle; aPA, anterior postalar 
bristle; aSA, anterior supraalar bristle; aSC, anterior scutellar bristle; HU,  humeral 
bristle. Humeral bristles are prothoracic structures that differentiate from first leg 
imaginal discs; they were always present in the ap>>hINSC96Y crosses, which is 
expressed in the mesothorax. Sco mutants, in contrast, often lack humeral bristles, as 
well as bristles typically lost in ap>>hINSC96Y flies. 
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Figure S3 Comparison of gene expression in 3rd instar eye imaginal discs from GMR-
Gal4 and GMR-Gal4 / UAS-hINSWT (Lines WT-6 and WT-24) and GMR-Gal4 / UAS-
hINSC96Y (Lines M-101 and M-1). (A) Venn diagram showing differential expression 
between GMR-Gal4 background and hINS transgenic lines in female larva. (B) Venn 
diagram showing differential expression between GMR-Gal4 background and hINS 
transgenic lines in male larva. Expression data were analyzed by sex with one-way 
ANOVA; significant genes were then tested to determine whether mean expression of 
hINSWT or hINSC96Y was significantly different from the GMR-Gal4 control (see Data 
analysis 1 in Material and Methods). 
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Figure S4 Alternative splicing of Xbp1 in RNA. RNA was isolated from eye imaginal 
discs of 3rd instar larva of indicated genotype. (A) RT-PCR and 10% PAGE analysis of 
the expression of the Xbp1-unspliced (U) and Xbp1- spliced (S) transcripts. Unspliced 
and spliced isoforms could be distinguished by the size of the PCR product (239 and 
216 bp, respectively). The PCR products were detected by ethidium bromide staining. 
(B) To further resolve the two isoforms, the PCR products were treated with PstI to 
cleave the unspliced form into fragments of 153 and 86 bp. 
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Figure S5 Campaniform sensilla on the wing: L3-v, ACV, L3-1, L3-2, L3-3 (black 
arrows). L2, L3, L4, and L5:  longitudinal veins of the wingblade are numbered. 
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Figure S6 Eye area in crosses of five DGRP lines to hINSC96Y is not correlated with  
wild type eye area. Five DGRP lines were sampled across the phenotypic distribution of 
the crosses with hINSC96Y, including the two extremes. They were crossed to a control 
line (GMR-Gal4), whose male progeny were measured for their eye area. No correlation 
is observed between results from the hINSC96Y cross and the GMR-Gal4 cross.	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Figure S7 GAL4 concentrations do not differ between DGRP lines in crosses to 
GMR>>hINSC96Y. (A) Western blot showing Gal4 bands in crosses between 
GMR>>hINSC96Y and five DGRP lines that were selected to span the range of eye 
phenotypes, as shown in Figure 5. (B) Mean value of Gal4 expression in two technical 
replicates. The density of the Gal4 band was normalized to β-actin (control); values 
shown are the fold change relative to male and female line 179.  
Method: Ten µg of total protein from cell lysates prepared from 20 adult heads was 
separated on a 10% SDS-PAGE, transferred to a PVDF membrane (Amersham 
Hybond™-P PVDF Transfer Membrane; GE Healthcare, Piscataway, NJ), and 
incubated with rabbit polyclonal anti-Gal4 primary antibody (Santa Cruz, CA; sc-577; 
1/1,000 dilution and a donkey anti-rabbit IgG-HRP secondary antibody (Santa Cruz, sc-
2096; 1/5,000 dilution). The blot was developed with Amersham ECL™ Western 
Blotting Detection Reagents and detected by chemiluminescence. The blot was also 
probed with a mouse β-actin antibody (Santa Cruz; sc-47778; 1/1,000 dilution) as a 
loading control. Band intensity was quantified using the Gel Analysis package in ImageJ 
Software (NIH).  
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Figure S8 Untransformed eye areas in F1 adults produced from crosses of Dr, L, or 
GMR>>hINSC96Y to DGRP lines. Data shown are mean ± SE. Although Dr and L eye 
area varies less than GMR>>hINSC96Y, the between-line (i.e., heritable) differences are 
comparable when scaled by within-line variances (Figure 6). 
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SUPPLEMENTARY TABLES 
 
Table S1 Primer sequences used for quantitative RT-PCR 
 
 	  	  	  	  	  	  	  	  	  	  	  
 
 
Gene                   Forward                   Reverse 
Human proinsulin CTACCTAGTGTGCGGGGAAC GCTGGTAGAGGGAGCAGATG 
CG4583 (Ire1) GAGATCACAGCGAACGACAA GGATAATTCGGCTGTCCTCA 
CG2087 (PEK) GTGGTTCTGGTGGAAGGAAA GGCACATGACGTTCAATGAC 
CG4147 (Hsc70-3) CAAGTTCGAGGAGCTCAACC AATCTCGTGCACGTCCTTCT 
CG9415 (Xbp1) AGAACCACAAGCTGGACTCG CAGATCCAAGGTTGGTGGAC 
CG3966  TGGCTGCCAGTTTTATGTGA CGGGTAGAACTCGAACTGCT 
CG7130 ACAAGATTCTGGGCATCGAG CGCGCTTTTCCTTATCAAAG 
CG10420 GGAGGCAAGACAAGCTGAAG TAGCTTGACCTTCCGCAATC 
CG10160 TTTAGAGGCGCCCAAAATAA GAGACGTTCTGAGCCAGGAT 
CG9150 CGAAGGTCACGTTCTCATCA TAACCCGGATTTTGTTCGAG 
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Table S2  Selected genes up-regulated by GMR-Gal4 / UAS-hINSC96Y in male eye imaginal discs 
Probe set Transcript Name Description (GO)1 Homolog2 
Transport     
1634512_at3  CG5226-RA CG5226 Carnitine transport SLC6A17 
1637439_at  CG14709-RA Mrp4 Transport ABCC4 
1635700_at3  CG31792-RA CG31792-RA Ion transport  
1627582_a_at  CG30035-RA Tret1 Trehalose transport SLC2A8 
1624450_at  CG6331-RA Orct Ion transport  
1623247_at3  CG10420-RA CG10420 Intracellular protein  
membrane transport 
SIL1 
1636800_at3  CG13610-RA Orct2 Ion transport  
1641606_s_at3  CG6608-RB Tpc1 Thiamine pyrophosphate  
transport 
 
1632622_ CG32538-RB GfA Ion transport  
1629040_at CG3476-RA CG3476 Ion transport  
1633039_at3  CG5646-RA CG5646 Mitochondrial transport  
(acyl carnitine) 
 
1627945_at3   CG4205-RA Fdxh Electron transport FDX1L 
1625250_at  CG5802-RA CG5802 Sugar transport SLC35B1 
1630804_at*  CG6417-RA Oatp33Eb Ion transport   
1633536_at   CG4630-RA CG4630 Transport  
1635684_a_at   CG2999-RA unc-13 Synaptic vesicle exocytosis UNC13C 
1641511_at  CG7394-RA TIM14 Membrane transport DNAJC19 
1623743_at CG3191-RA CG3191 Transport  
1631763_at   CG31793-RA  CG31793  Transport ABCC4 
1637280_at  CG4861-RA  LpR1 Receptor-mediated  
endocytosis  
VLDLR 
1640075_a_at   CG3424-RA  pathetic Transport  
1640220_a_at   CG11779-RA  CG11779  Transport TIMM44 
1633304_at  CG1967-RA  p24-1 Post-Golgi vesicle-mediated transport TMED7 
1632676_s_at3 CG11897-RA  CG11897 Transport  
1637772_at   CG4726-RA  MFS3 Ion transport  
1631856_a_at CG7361-RB RFeSP Transport UQCRFS1 
Oxidation-reduction  
1635227_at3 CG10160-RA ImpL3 Oxidoreductase LDHA 
1639033_at3   CG9432-RB l(2)01289 Oxidoreductase  
1638053_at3  CG10842-RA Cyp4p1 Oxidoreductase  
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1637063_at  CG33099-RA CG33099 Oxidoreductase  
1623971_at3  CG9150-RA  CG9150 Oxidoreductase  
1623787_at  CG7144-RA  CG7144 Oxidoreductase AASS  
1627525_a_at CG1333-RA  Ero1L Oxidoreductase ERO1LB 
1630885_at3  CG12534-RA  Alr Oxidoreductase GFER 
1627945_at3  CG4205-RA Fdxh Oxidoreductase FDX1L 
1638006_at  CG10211-RA CG10211 Oxidoreductase  
1633687_at  CG13611-RA CG13611 Oxidoreductase  
1636759_at  CG8303-RA CG8303 Oxidoreductase   
1624571_s_at3  CG32857-RA CG32857 Oxidoreductase  
1624003_at  CG10639-RA CG10639 Oxidoreductase  
1634019_at  CG2064-RA CG2064 Oxidoreductase RDH12 
1640566_at  CG1944-RA Cyp4p2 Oxidoreductase  
1632676_s_at3  CG11897-RA CG11897 Oxidoreductase  
1631856_a_at  CG7361-RB RFeSP Oxidoreductase UQCRFS1 
1633238_at  CG17533-RA GstEB Oxidoreductase  
1630258_at  CG4181-RA GstD2 Oxidoreductase  
Mitochondrial protein 
1634658_a_at CG8772-RD Nemy Mitochondrion GLS  
1641606_s_at3  CG6608-RB Tpc1 Mitochondrion  
1629040_at  CG3476-RA CG3476 Mitochondrion  
1633039_at3  CG5646-RA CG5646 Mitochondrion  
1630885_at3   CG12534-RA Air Mitochondrion GFER 
1639676_at3  CG15173-RA Ttc19 Mitochondrion  
1627945_at3  CG4205-RA Fdxh Mitochondrion FDX1L 
1641511_at CG7394-RA TIM14 Mitochondrion DNAJC19 
1626460_at         C  G2658-RA CG2658 Mitochondrion  
1627034_a_a  CG9410-RB Coq10 Mitochondrion  
1640220_a_at  CG11779-RA CG11779 Mitochondrion TIMM44 
1627939_a_at3  CG2098-RA Fech Mitochondrion FECH 
1625763_at  CG2789-RA CG2789 Mitochondrion TSPO 
1640566_at  CG1944-RA Cyp4p2 Mitochondrion  
1631856_a_at  CG7361-RB RFeSP Mitochondrion UQCRFS1 
1634899_a_at  CG6512-RA CG6512 Mitochondrion AFG3L2 
1 GO molecular function/process from www.flybase.org, www.uniprot.org and www.david.abcc.ncifcrf.gov 
        2 Human homolog from www.flight.icr.ac.uk 
        3 Up-regulated in female and male 
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       Table S3.  Selected genes down-regulated by GMR-Gal4 / UAS-hINSC96Y in male eye imaginal discs 
Probe set Transcript Name Description (GO)1 Homolog2 
Regulation of transcription  
1624663_a_at3 CG8821-RA Vismay  DNA binding  
1635500_a_at  CG17228-RA Prospero  DNA binding  
1631408_at  CG18024-RA SoxNeuro  DNA binding SOX1 
1633592_a_at  CG5413-RB CREG  Transcription repressor CREG1 
1630105_at  CG3891-RA Nuclear factor Y-box A DNA binding NFYA 
1636931_at  CG11491-RD Broad  DNA binding QRFPR 
1626045_at3  CG31318-RA Rpb4   Transcription factor TADA2L 
1639732_s_at4 CG4881-RA Spalt-related  RNA polymerase II 
Transcription factor 
SALL1 
Ion Binding     
1638311_at  CG12817-RA CG12817      Ion binding  
1633488_at4  CG3705-RA astray     Ion binding PSPH 
1630163_at3  CG32373-RA CG32373    Ion binding  
1629347_at  CG12296-RA klu      Ion binding  
1633000_a_at  CG7100-RA CadN   Ion binding SQRDL 
1641652_a_at  CG33166-RB stet     Ion binding RHBDL3 
1630504_at  CG13830-RA CG13830    Ion binding  
1636602_at  CG11253-RA CG11253     Ion binding  
1624001_at  H DC07119 Scribbler   Ion binding  
1624617_at  CG1665-RA CG1665     Ion binding  
1630434_a_at  CG31064-RA CG31064    Ion binding RUFY2 
1639969_at  CG6969-RA Cardinal      Ion binding  
1635447_at  CG4827-RA veil    Ion binding NT5E 
1636931_at  CG11491-RD Broad     Ion binding QRFPR 
1626045_at3  CG31318-RA Rpb4      Ion binding TADA2L 
1635580_at CG7037-RB Cbl     Ion binding CBL 
1624039_at  CG10147-RA CG10147   Ion binding  
1638682_a_at  CG11988-RC Neur     Ion binding NEURL1B 
1640696_at  CG17803-RA CG17803    Ion binding  
Enzyme activity 
1633488_at4  CG3705-RA Astray  Phosphatase PSPH 
1624505_at  CG6113-RA Lip4    Lipase LIPA 
1634351_at4  CG7860-RA CG7860 Asparaginase  
1627360_at   CG31349-RF Polychaetoid    Guanylate kinase TJP1 
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1626045_at3  CG31318-RA Rpb4      Acetyltransferase TADA2L 
1623299_at3                                       CG1794-RA Mmp2   Endopeptidase MMP2 
1628149_a_at3 CG14895-RB Pak3      Protein kinase PAK3 
 
1 GO molecular function/process from www.flybase.org, www.uniprot.org and www.david.abcc.ncifcrf.gov 
2 Human homolog from www.flight.icr.ac.uk 
3 Down-regulated in female and male 
4 Down-regulated only in female  
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Table S4.  Functional annotation clustering 
Database Keywords    Count           P-value 
Cluster_1 Enrichment_Score: 2.4 
SP_PIR_KEYWORDS Membrane 40 3.10E-04 
GOTERM_CC_FAT Integral to membrane 40 0.004 
GOTERM_CC_FAT Intrinsic to membrane 40 0.006 
SP_PIR_KEYWORDS Transmembrane 33 0.006 
UP_SEQ_FEATURE Transmembrane region 19 0.026 
 
Cluster_2 Enrichment_Score: 1.38    
GOTERM_CC_FAT Cell projection 7 0.021 
GOTERM_CC_FAT Neuron projection 4 0.054 
GOTERM_CC_FAT Dendrite 3 0.063 
    
Cluster_3 Enrichment_Score: 1.32    
GOTERM_MF_FAT Iron-sulfur cluster binding 6 0.004 
GOTERM_MF_FAT Metal cluster binding 6 0.004 
SP_PIR_KEYWORDS 2Fe-2S 3 0.022 
GOTERM_MF_FAT 2 iron, 2 sulfur cluster binding 3 0.046 
SP_PIR_KEYWORDS Iron-sulfur 3 0.089 
SP_PIR_KEYWORDS Mitochondrion 7 0.150 
SP_PIR_KEYWORDS Transit peptide 4 0.380 
UP_SEQ_FEATURE Transit peptide:Mitochondrion 4 0.400 
 
Cluster_4 Enrichment_Score: 1.12    
SMART DnaJ 4 0.054 
INTERPRO Heat shock protein DnaJ, N-terminal 4 0.059 
GOTERM_MF_FAT Heat shock protein binding 4 0.061 
INTERPRO 
Molecular chaperone, heat shock 
protein, Hsp40, DnaJ 3 0.180 
In total 385 probe sets identified as differentially expressed in either sexes were used in this analysis. 30 
of the 385 probe_sets were removed in the most recent Affymetrix annotation, leaving 355. Functional 
annotation clustering were done using the DAVID web service (ref), with the default choice of annotation 
terms (excluding GOTERM_BP_FAT) and medium clustering criteria. Changing either the terms or the 
clustering criteria won't affect the general result. For example, the heat shock protein cluster is always 
among the top clusters in various settings. 	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Table S5 Quantitative RT-PCR 
    
     Gene 
    
     GMR-Gal4 
 
GMR-Gal4 / UAS-hINSWT 
 
GMR-Gal4 / UAS-hINSC96Y 
            WT-6      WT-24       M-101        M-1 
Ire1 1.05 ± 0.23 1.12 ± 0.12 1.37 ± 0.28 1.99 ± 0.22 
(P=0.04) 
1.78 ± 0.23 
(P=0.08) 
PEK1 1.00 ± 0.04 0.89 ± 0.11 1.11 ± 0.13 1.99 ± 0.15 
(P=0.003) 
1.98 ± 0.15 
(P=0.0007) 
Hsc70-32 
 
1.11 ± 0.36 0.91 ± 0.27 0.74 ±0.07 
(P=0.38) 
1.50 ± 0.06 2.75 ± 0.22 
(P=0.0176) 
Xbp1 1.05 ± 0.25 1.50 ± 0.24 1.55 ± 0.23  2.03 ± 0.17 
(P=0.03) 
2.22 ± 0.25 
(P=0.03) 
Comparison of gene expression of upstream regulators of UPR in male 3rd instar larval eye imaginal discs 
is shown. The results was normalized to the expression level of rp49 and compared to GMR-Gal4 using 
an unpaired t-test. The data are shown as mean ± SE and the exact P-values are shown.  
1 Human homolog of PKR-like ER kinase (PERK) 
2 Human homolog of BiP (also known as GRP78) 	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Table S6 Comparison of gene expression levels by microarray and quantitative RT-PCR 
A.  Microarray 
 
Gene 
 
GMR-Gal4 
 
GMR-Gal4 / UAS-hINSWT 
 
GMR-Gal4 / UAS-hINSC96Y 
  WT-6 WT-24 M-101 M-1 
CG3966 1.00 ± 0.23 0.89 ± 0.00 0.87 ± 0.12 1.32 ± 0.09 6.27 ± 1.08* 
CG7130 1.00 ± 0.02 0.96 ± 0.02 1.12 ± 0.14 1.78 ± 0.04* 3.90 ± 0.36* 
CG10420 1.00 ± 0.09 1.03 ± 0.05 0.96 ± 0.07 1.98 ± 0.07* 2.55 ± 0.37* 
 CG10160 1.00 ± 0.13 1.36 ± 0.15 1.03 ±0.15 12.63 ± 0.16* 15.45 ± 1.76* 
CG9150 1.00 ± 0.02 1.03 ± 0.02 0.85 ± 0.15 1.80 ± 0.06* 2.70 ± 0.56* 
 
B.   Quantitative RT-PCR 
 
Gene 
 
GMR-Gal4 
 
GMR-Gal4 / UAS-hINSWT 
 
GMR-Gal4 / UAS-hINSC96Y 
   WT-6 WT-24 M-101 M-1 
 CG3966   1.01 ± 0.08 0.98 ± 0.08 1.16 ± 0.05 1 .97 ± 0.14* 9.1 ± 0.93* 
CG7130 1.00 ± 0.02 0.84 ± 0.21 0.99 ± 0.03 1.66 ± 0.13* 4.03 ± 0.71* 
CG10420 1.01 ± 0.08 1.12 ± 0.06 1.03 ± 0.14 4.81 ± 0.43* 11.77 ± 0.44* 
 CG10160 1.01 ± 0.09 1.11 ± 0.35 0.70 ± 0.22 234.64 ± 80.76* 378 ± 64.08* 
CG9150 1.02 ± 0.12 1.18 ± 0.32 1.02 ± 0.08 2.49 ± 0.07* 3.73 ± 0.38* 
Gene expression was normalized to the expression level of rp49 and compared to GMR-Gal4 using an 
unpaired t-test. Data are shown as mean ± SE.  
* P < 0.05 	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Table S7 Number of Missing Bristles  
  
ap>>hINSC96Y/ CyO 
 
ap>>hINSC96Y X W1118 
 
Sco X w1118 
Female   6.56 ±  1.80         8.32 ±  2.14 9.20 ±1.44 
Male 10.92 ±  2.33       13.36 ±  2.48 9.36 ±1.32 
We recombined the ap-GAL4 driver onto the chromosome containing the M-1 UAS-hINSC96Y transgene to 
create ap>>hINSC96Y. Sco (Scutoid) also reduces bristles on the notum to approximately the same level 
as mutant hINS. We used Sco in a control cross to investigate whether it has a sex-biased bristle 
phenotype. The fact that it does not suggests that the sex-biased phenotype produced by mutant hINS 
may not be through sex-specific inputs to bristle formation but rather through a physiological difference in 
the response of male and female somatic cells to mutant hINS protein. Data are shown as mean ±  SD. 	  	  
Table S8 Missing or displaced companiform sensilla 
 
Sex 
 
en>>hINSWT 
 
en>>hINSC96Y 
 
dpp>>hINSWT 
 
dpp>>hINSC96Y 
Female 0 7 0 11 
Male 0 4 1 14 
We examined four sensilla — one on the ACV and three along L3 (see Figure S5) — from one wing in 10 
individuals. Tabulated are the total number of displaced sensillae out of 40. 
 
 
 
 
Table S9 Correlation between mutations and sexes 
	    
          Drop	  
 
          Lobe	  
 
GMR>>hINSC96Y	  
 
ap>>hINSC96Y	  
Drop	   0.63*	   0.2	             0.06	             -0.19	  
Lobe	             0.09 0.53*           0.08	             -0.12	  
GMR>>hINSC96Y	             0.13          -0.07           0.88*           -0.23	  
ap>>hINSC96Y	            -0.19           0.29          -0.17            0.67*	  
Diagonal elements are correlations between the two sexes for each mutation group; the upper triangle 
contains correlations between males in the respective mutation groups, and numbers in the lower triangle 
area are for females.	  Pearson's correlation is calculated for all pairs except those involving the bristle 
number, in which case the Spearman's correlation (rank correlation) is calculated. * indicates a correlation 
test P < 0.05 (P-values corrected for multiple testing using Bonferroni method)	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Table S10 Effect of genetic variation on eye area and bristle number in females	  
  
    GMR>>INSC96Y 
 
         Drop 
 
         Lobe 
 
ap>>INSC96Y 
DGRP Line Eye area Eye area Eye area Number of Bristles 
RAL-208 64.58 ± 6.99 14.60 ± 4.01 94.66 ± 5.69 23.1 ± 2.0 
RAL-301 66.59 ± 5.81 16.88 ± 3.88 97.50 ± 4.73 25.2 ± 1.0 
RAL-303 61.25 ± 6.32 14.01 ± 1.88 94.54 ± 4.86 24.5 ± 1.5 
RAL-304  66.87 ± 27.85 14.63 ± 2.43 97.36 ± 5.79 23.8 ± 1.9 
RAL-307 80.10 ± 8.11 15.08 ± 4.20 101.84 ± 6.73 25.7 ± 0.5 
RAL-313 68.62 ± 5.47 14.22 ± 4.33 91.99 ± 8.85 25.8 ± 0.5 
RAL-315 47.58 ± 4.55  9.61 ± 1.82 82.04 ± 4.74 23.9 ± 2.2 
RAL-324 67.72 ± 4.65 11.02 ± 1.92 NA 24.9 ± 0.9 
RAL-335 63.11 ± 6.28 12.38 ± 1.82 96.48 ± 7.63 18.6 ± 2.1 
RAL-357  68.49 ± 11.45 13.53 ± 2.19 86.01 ± 9.87 25.6 ± 0.6 
RAL-358 70.18 ± 4.91 16.39 ± 3.63 95.36 ± 6.01 25.2 ± 1.3 
RAL-360 69.02 ± 6.85 13.30 ± 2.60  95.21 ±13.73 23.9 ± 1.4 
RAL-362 37.29 ± 4.37 24.21 ± 8.91 98.77 ± 7.44 24.8 ± 1.0 
RAL-375 55.85 ± 6.87 14.05 ± 1.83 91.55 ± 5.53 24.0 ± 1.3 
RAL-379 59.42 ± 6.15 16.02 ± 3.10 98.02 ± 5.42 24.4 ± 1.2 
RAL-380 69.96 ± 4.07 11.89 ± 1.83 93.38 ± 5.33 20.5 ± 2.1 
RAL-391 48.63 ± 6.85 15.43 ± 4.56 87.50 ± 8.92 23.8 ± 2.2 
RAL-399 43.31 ± 8.51 13.75 ± 2.93 97.43 ± 8.47 25.2 ± 0.9 
RAL-427  53.88 ± 12.51 19.65 ± 6.10 96.57 ± 9.69 25.8 ± 0.5 
RAL-437 70.21 ± 8.30 16.73 ± 3.03 101.10 ± 5.44 23.5 ± 1.4 
RAL-486 60.40 ± 5.79 17.66 ± 3.51 96.22 ± 6.41 23.4 ± 1.3 
RAL-426 63.41 ± 8.99 12.88 ± 1.58 95.91 ± 7.65 23.3 ± 1.5 
RAL-517 71.37 ± 5.08 10.40 ± 1.87 104.17 ± 6.48 24.6 ± 1.2 
RAL-555 56.32 ± 8.91 13.77 ± 3.18 101.21 ± 5.35 23.0 ± 1.9 
RAL-639  28.56 ± 15.68 13.60 ± 2.78 95.42 ± 5.39 23.2 ± 2.1 
RAL-707 71.94 ± 6.69 14.27 ± 2.12 103.78 ± 6.82 25.2 ± 0.9 
RAL-712 59.56 ± 6.67 13.57 ± 3.86 73.41 ± 22.28 25.7 ± 0.7 
RAL-730 61.14 ± 10.99 14.54 ± 2.89 101.73 ± 5.57 25.3 ± 1.0 
RAL-732 55.86 ± 7.85 12.50 ± 1.80 96.72 ± 8.16 23.9 ± 1.5 
RAL-765 50.59 ± 11.68 13.56 ± 1.74 62.45 ± 20.45 24.0 ± 0.8 
RAL-774 67.71 ± 7.20 13.68 ± 2.19 91.80 ± 7.02 25.8 ± 0.4 
RAL-786 54.59 ± 7.48 12.54 ± 1.76 94.26 ± 6.55 25.6 ± 0.6 
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RAL-799 59.45 ± 5.81 13.21 ± 3.85 99.35 ± 7.31 24.0 ± 1.2 
RAL-820 55.22 ± 10.40 14.10 ± 2.23 101.15 ± 5.98 25.1 ± 1.0 
RAL-852 72.05 ± 6.21 14.60 ± 3.26 81.69 ± 16.53 24.8 ± 0.9 
RAL-365 76.59 ± 4.88 14.03 ± 3.49 99.59 ± 7.13 25.4 ± 0.9 
RAL-705 52.63 ± 7.89 13.68 ± 2.14 95.56 ± 7.65 24.4 ± 1.1 
RAL-714 68.74 ± 6.30 12.54 ± 3.62           NA 25.0 ± 1.2 
The eye area or dorsal bristle number were measured in 10 individuals. The eye area (pixels × 103) and 
number of bristles are shown as mean ± SE.   
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Table S11 Effect of genetic variation on eye area and bristle number in males 
  
GMR>>INSC96Y 
 
Drop 
 
Lobe 
 
ap>>INSC96Y 
DGRP Line Eye area Eye area Eye area Number of Bristles 
RAL-208 25.55 ± 4.76   9.15 ± 2.71 80.79 ± 7.57 19.8 ± 1.5 
RAL-301 32.33 ± 5.56 11.16 ± 3.14 73.46 ± 6.20 18.3 ± 3.9 
RAL-303 31.41 ± 6.53   9.87 ± 2.99 73.67 ± 5.44 23.3 ± 1.6 
RAL-304 39.92 ± 7.34 10.87 ± 4.85 76.08 ± 6.08 21.0 ± 2.0 
RAL-307 46.12 ± 7.40 15.56 ± 4.26 91.04 ± 7.14 23.4 ± 1.5 
RAL-313 36.76 ± 6.94   8.25 ± 1.89 86.30 ± 5.75 24.7 ± 1.4 
RAL-315 22.38 ± 2.72   6.68 ± 2.12 73.13 ± 4.60 19.8 ± 1.8 
RAL-324 44.29 ± 4.23   7.98 ± 2.92 75.63 ± 4.38 23.4 ± 1.1 
RAL-335 35.77 ± 4.32   8.02 ± 2.39 77.02 ± 5.83 11.0 ± 1.1 
RAL-357 36.14 ± 4.49 11.80 ± 3.11 81.68 ± 6.35 25.1 ± 1.2 
RAL-358 34.04 ± 6.96 11.84 ± 4.18 82.04 ± 7.65 22.4 ± 2.0 
RAL-360  30.18 ± 10.04 12.16 ± 3.32 85.21 ± 6.17 22.4 ± 1.8 
RAL-362 70.52 ± 7.21 13.10 ± 5.01 82.63 ± 4.26 24.0 ± 1.1 
RAL-375 29.00 ± 5.43 12.65 ± 2.79 83.53 ± 6.19 20.1 ± 2.5 
RAL-379 27.05 ± 5.47 12.22 ± 3.35 85.32 ± 4.69 21.6 ± 2.2 
RAL-380 36.80 ± 6.07   9.01 ± 2.70 80.68 ± 6.72 13.7 ± 2.2 
RAL-391 13.83 ± 3.61 13.57 ± 4.38 70.53 ± 6.69 21.9 ± 1.9 
RAL-399 10.65 ± 3.48 10.03 ± 3.37 81.53 ± 5.45 17.9 ± 2.5 
RAL-427 25.96 ± 5.16 14.30 ± 3.63 87.13 ± 4.94 25.6 ± 0.7 
RAL-437 33.82 ± 7.29 13.15 ± 3.60 85.73 ± 5.73 20.7 ± 2.3 
RAL-486 30.94 ± 6.10 11.30 ± 4.44 89.08 ± 5.77 22.4 ± 1.8 
RAL-426 30.93 ± 6.49   9.16 ± 2.82 80.82 ± 5.12 20.6 ± 2.0 
RAL-517 29.32 ± 4.64   5.27 ± 1.09 90.12 ± 3.94 21.5 ± 1.9 
RAL-555 23.27 ± 4.74   9.55 ± 2.63 83.83 ± 5.54 21.9 ± 1.9 
RAL-639   7.13 ± 4.47   8.40 ± 2.25 84.64 ± 6.59 21.1 ± 2.2 
RAL-707 34.95 ± 7.72   9.97 ± 3.12 78.70 ± 7.26 23.4 ± 1.4 
RAL-712 31.96 ± 7.29   9.55 ± 2.42 80.80 ± 6.80 23.8 ± 1.4 
RAL-730 23.92 ± 9.50 15.32 ± 7.03 77.42 ± 5.74 22.6 ± 1.5 
RAL-732 21.65 ± 5.90 10.90 ± 4.01 84.35 ± 6.96 19.6 ± 2.5 
RAL-765 13.46 ± 5.90   9.62 ± 2.12 80.69 ± 5.55 19.7 ± 1.6 
RAL-774 24.75 ± 5.48   8.49 ± 1.94 69.95 ± 6.60 25.5 ± 0.7 
RAL-786 22.51 ± 5.73 11.58 ± 3.17 83.99 ± 6.38 24.7 ± 1.5 
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RAL-799 24.51 ± 7.25   9.10 ± 2.72 81.61 ± 3.29 21.0 ± 2.1 
RAL-820 21.97 ± 6.59 10.59 ± 4.59 82.90 ± 4.00 24.3 ± 1.7 
RAL-852 34.65 ± 7.39 10.82 ± 2.65 86.58 ± 4.90 14.1 ± 2.8 
RAL-365 43.91 ± 5.69   9.45 ± 2.96 77.41 ± 4.70 23.9 ± 1.4 
RAL-705 13.90 ± 3.58 10.40 ± 4.10 82.48 ± 7.07 18.8 ± 2.4 
RAL-714 42.56 ± 5.22 10.05 ± 3.41 84.19 ± 4.99 24.0 ± 1.9 
The eye area or dorsal bristle number were measured in 10 individuals. The eye area (pixels × 103) and 
number of bristles are shown as mean ± SE.  	  	  
